Cardiovascular Diagnostic Procedures

Published on 07/03/2015 by admin

Filed under Critical Care Medicine

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 5 (1 votes)

This article have been viewed 4260 times

Chapter 14

Cardiovascular Diagnostic Procedures

Mary E. Lough and Christine Thompson

Cardiovascular Assessment and Monitoring

Bedside Hemodynamic Monitoring

Hemodynamic monitoring is at a critical juncture. The technology that launched invasive hemodynamic monitoring is more than 30 years old, and the search to find viable replacement monitoring technologies that are minimal or noninvasive is intense. This has created a new challenge in critical care. Although the use of invasive monitoring is declining, it is still employed for hemodynamically unstable patients. Critical care nurses must be knowledgeable about traditional hemodynamic monitoring methods and be able to apply established physiologic principles in new situations. As the technology evolves, clinicians will apply the same physiologic principles to the new methods to ensure safety and optimal outcomes for each patient. The following discussion of hemodynamic monitoring describes both established and emerging technologies.

Equipment

A traditional hemodynamic monitoring system has four component parts as shown in Figure 14-1 and described in the following list:

Although many different types of invasive catheters can be inserted to monitor hemodynamic pressures, all such catheters are connected to similar equipment (see Fig. 14-1). Even so, there remains variation in the way different hospitals configure their hemodynamic systems. The basic setup consists of the following:

Heparin. 

The use of the anticoagulant heparin added to the normal saline (NS) flush setup to maintain catheter patency remains controversial.1,2 While many units do add heparin to flush solutions, other critical care units avoid heparin because of concern about development of heparin-induced antibodies that can trigger the autoimmune condition known as heparin-induced thrombocytopenia (HIT).2 This is sometimes described as a “heparin allergy” and, when present, is associated with a dramatic drop in platelet count and thrombus formation. If heparin is used in the flush infusion, ongoing monitoring of the platelet count is recommended.3

Flush solutions, lines, stopcocks, and disposable transducers are changed every 96 hours per current Centers for Disease Control and Prevention (CDC) guidelines.4 However, there is variation in practice between hospitals; some change the flush solutions every 24 hours. For this reason, it is essential to be familiar with the specific written procedures that concern hemodynamic monitoring equipment in each critical care unit. Dextrose solutions are not recommended as flush solutions in monitoring catheters.4

Zeroing the Transducer. 

To calibrate the equipment to atmospheric pressure, referred to as zeroing the transducer, the three-way stopcock nearest to the transducer is turned simultaneously to open the transducer to air (atmospheric pressure) and to close it to the patient and the flush system. The monitor is adjusted so that “0” is displayed, which equals atmospheric pressure. Atmospheric pressure is not zero; it is 760 mm Hg at sea level. Using zero to represent current atmospheric pressure provides a convenient baseline for hemodynamic measurement purposes.

Some monitors also require calibration of the upper scale limit while the system remains open to air. At the end of the calibration procedure, the stopcock is returned to the closed position and a closed cap is placed over the open port. At this point, the patient’s waveform and hemodynamic pressures are displayed.

Disposable transducers are very accurate, and after they are calibrated to atmospheric pressure, drift from the zero baseline is minimal. Although in theory this means that repeated calibration is unnecessary, clinical protocols in most units require the nurse to calibrate the transducer at the beginning of each shift for quality assurance.

Phlebostatic Axis. 

The phlebostatic axis is a physical reference point on the chest that is used as a baseline for consistent transducer height placement. To locate the level of the phlebostatic axis, an imaginary vertical line is drawn from the fourth intercostal space where it joints the sternum to a horizontal line that is midway between the anterior and posterior chest walls. The midaxillary line is one half of the anteroposterior depth of the lateral chest wall.5 This point approximates the level of the atria, as shown in Figure 14-1. It is used as the reference mark for central venous pressure (CVP) and pulmonary artery catheter transducers. The level of the transducer “air reference stopcock” approximates the position of the tip of an invasive hemodynamic monitoring catheter within the chest.

Leveling the Transducer. 

Leveling the transducer is different from zeroing. This process aligns the transducer with the level of the left atrium. The purpose is to line up the air–fluid interface with the left atrium to correct for changes in hydrostatic pressure in blood vessels above and below the level of the heart.5

A carpenter’s level or laser-light level can be used to ensure that the transducer is parallel with the phlebostatic axis reference point. When there is a change in the patient’s position, the transducer must be leveled again to ensure accurate hemodynamic pressure measurements are obtained.5 Errors in measurement can occur if the transducer is placed below the phlebostatic axis because the fluid in the system weighs on the transducer, creating additional hydrostatic pressure, and produces a falsely high reading. For every inch the transducer is below the tip of the catheter, the fluid pressure in the system increases the measurement by 1.87 mm Hg. For example, if the transducer is positioned 6 inches below the tip of the catheter, this falsely elevates the displayed pressure by 11 mm Hg.

If the transducer is placed above this atrial level, gravity and lack of fluid pressure will give an erroneously low reading. For every inch the transducer is positioned above the catheter tip, the measurement is 1.87 mm Hg less than the true value. If several clinicians are taking measurements, the reference point can be marked on the side of the patient’s chest to ensure accurate measurements. Box 14-1 summarizes other nursing activities associated with hemodynamic monitoring.

image Box 14-1

NIC

Invasive Hemodynamic Monitoring

Definition

Measurement and interpretation of invasive hemodynamic parameters to determine cardiovascular function and regulate therapy as appropriate

Activities

Assist with insertion and removal of invasive hemodynamic lines

Assist with Allen test for evaluation of collateral ulnar circulation before radial artery cannulation, if appropriate

Assist with chest radiograph examination after insertion of pulmonary artery catheter

Monitor heart rate and rhythm

Zero and calibrate equipment every 4 to 12 hours, as appropriate, with transducer at the level of the right atrium

Monitor blood pressure (systolic, diastolic, and mean), central venous/right atrial pressure, pulmonary artery pressure (systolic, diastolic, and mean), and pulmonary capillary/artery wedge pressure

Monitor hemodynamic waveforms for changes in cardiovascular function

Compare hemodynamic parameters with other clinical signs and symptoms

Use closed-system cardiac output setup

Obtain cardiac output by administering cardiac output injectate within 4 seconds, and average three injections that are within less than 1 L of each other

Monitor pulmonary artery and systemic arterial waveforms; if dampening occurs, check tubing for kinks or air bubbles, check connections, aspirate clot from tip of catheter, gently flush system, or assist with repositioning of catheter

Document pulmonary artery and systemic arterial waveforms

Monitor peripheral perfusion distal to catheter insertion site every 4 hours or as appropriate

Monitor for dyspnea, fatigue, tachypnea, and orthopnea

Monitor for forward progression of pulmonary catheter resulting in spontaneous wedge, and notify physician if it occurs

Refrain from inflating balloon more frequently than every 1 to 2 hours, or as appropriate

Monitor for balloon rupture (e.g., assess for resistance when inflating balloon and allow balloon to passively deflate after obtaining pulmonary artery occlusion pressure [PAOP])

Prevent air emboli (e.g., remove air bubbles from tubing; if balloon rupture is suspected, refrain from attempts to reinflate balloon and clamp balloon port)

Maintain sterility of ports

Maintain closed-pressure system to ports, as appropriate

Perform sterile dressing changes and site care, as appropriate

Inspect insertion site for signs of bleeding or infection

Change IV solution and tubing every 24 to 96 hours, based on protocol

Monitor laboratory results to detect possible catheter-induced infection

Administer fluid and/or volume expanders to maintain hemodynamic parameters within specified range

Administer pharmacologic agents to maintain hemodynamic parameters within specified range

Instruct patient and family on therapeutic use of hemodynamic monitoring catheters

Instruct patient on activity restriction while catheters remain in place

Modified from Bulechek GM, et al. Nursing interventions classification (NIC). 6th ed. St. Louis: Mosby; 2013.

Patient Position

Position of the hemodynamically monitored patient would not be an issue if critical care patients only lie flat in the bed. However, lying flat is not always a comfortable position, especially if the patient is alert or if the head of the bed needs to be elevated to decrease the work of breathing.

Head of Bed Backrest Position. 

Nurse researchers have determined that the CVP, pulmonary artery pressure (PAP), and pulmonary artery occlusion pressure (PAOP)—also called pulmonary artery wedge pressure (PAWP)—can be reliably measured at head of bed backrest positions from 0 (flat) to 60 degrees if the patient is lying on his or her back (supine).5,6 If the patient is normovolemic and hemodynamically stable, raising the head of the bed usually does not affect hemodynamic pressure measurements. If the patient is so hemodynamically unstable or hypovolemic that raising the head of the bed negatively affects intravascular volume distribution, the first priority is to correct the hemodynamic instability and leave the patient in a lower backrest position. In summary, most patients do not need the head of the bed to be lowered to 0 degrees to obtain accurate CVP, PAP, or PAOP readings.

Lateral Position. 

The landmarks for leveling the transducer are different if the patient is turned to the side. Researchers have evaluated hemodynamic pressure measurement readings with the patients in the 30- and 90-degree lateral positions with the head of the bed flat, and they found the measurements to be reliable.5 In the 30-degree angle position, the landmark to use for leveling the transducer is one half of the distance from the surface of the bed to the left sternal border.5 In the 90-degree right-lateral position, the transducer fluid–air interface was positioned at the fourth ICS at the midsternum. In the 90-degree left-lateral position, the transducer was positioned at the left parasternal border (beside the sternum).5 It is important to know that measurements can be recorded in nonsupine positions, because critically ill patients must be turned to prevent development of pressure ulcers and other complications of immobility.

Intra-arterial Blood Pressure Monitoring

Indications

Intra-arterial blood pressure monitoring is indicated for any major medical or surgical condition that compromises cardiac output (CO), tissue perfusion, or fluid volume status. The system is designed for continuous measurement of three blood pressure parameters: systole, diastole, and mean arterial blood pressure (MAP). The direct arterial access is helpful in the management of patients with acute respiratory failure who require frequent arterial blood gas measurements.

Catheters

The size of the catheter used is proportionate to the diameter of the cannulated artery. In small arteries—such as the radial and dorsalis pedis—a 20-gauge, 3.8-cm to 5.1-cm, nontapered catheter is used most often. If the larger femoral or axillary arteries are used, a 19- or 20-gauge, 16-cm catheter is used.

The catheter insertion is usually percutaneous, although the technique varies with vessel size. Catheters are most often inserted in the smaller arteries, using a “catheter-over-needle” unit in which the needle is used as a temporary guide for catheter placement. With this method, after the unit has been inserted into the artery, the needle is withdrawn, leaving the supple plastic catheter in place. Insertion of a catheter into a larger artery typically uses the Seldinger technique, which involves the following steps:

Insertion and Allen Test. 

Several major peripheral arteries are suitable for receiving a catheter and for long-term hemodynamic monitoring. The most frequently used site is the radial artery.2 The femoral artery is a larger vessel that is also frequently cannulated. Other smaller arterials such as the dorsalis-pedis, axillary, or brachial arteries are avoided if possible, and only used when other arterial access is unavailable.

The major advantage of the radial artery is the supply of collateral circulation to the hand provided by the ulnar artery through the palmar arch in most people. Before radial artery cannulation, collateral circulation must be assessed by using Doppler flow or by the modified Allen test according to institutional protocol.2,7 In the Allen test the radial and ulnar arteries are compressed simultaneously. The patient is asked to clench and unclench the hand until it blanches. One of the arteries is then released, and the hand should immediately flush from that side. The same procedure is repeated for the remaining artery.

Nursing Management

Intra-arterial blood pressure monitoring is designed for continuous assessment of arterial perfusion to the major organ systems of the body. MAP is the clinical parameter most often used to assess perfusion, because MAP represents perfusion pressure throughout the cardiac cycle. Because one third of the cardiac cycle is spent in systole and two thirds in diastole, the MAP calculation must reflect the greater amount of time spent in diastole.8 This MAP formula can be calculated by hand or with a calculator, where diastole times 2 plus systole is divided by 3 as shown in the formula below:

< ?xml:namespace prefix = "mml" />(Diastole×2)+(Systole×1)3=MAP

image

A blood pressure of 120/60 mm Hg produces a MAP of 80 mm Hg. However, the bedside hemodynamic monitor may show a slightly different digital number because bedside monitoring computers calculate the area under the curve of the arterial line tracing8 (Table 14-1).

TABLE 14-1

HEMODYNAMIC PRESSURES AND CALCULATED HEMODYNAMIC VALUES

HEMODYNAMIC PRESSURE DEFINITION AND EXPLANATION NORMAL RANGE
Mean arterial pressure (MAP) Average perfusion pressure created by arterial blood pressure during the cardiac cycle. The normal cardiac cycle is one third systole and two thirds diastole. These three components are divided by 3 to obtain the average perfusion pressure for the whole cardiac cycle. 70-100 mm Hg
Central venous pressure (CVP) Pressure created by volume in the right side of the heart. When the tricuspid valve is open, the CVP reflects filling pressures in the right ventricle. Clinically, the CVP is often used as a guide to overall fluid balance. 2-5 mm Hg
3-8 cm water (H2O)
Left atrial pressure (LAP) Pressure created by the volume in the left side of the heart. When the mitral valve is open, the LAP reflects filling pressures in the left ventricle. Clinically, the LAP is used after cardiac surgery to determine how well the left ventricle is ejecting its volume. In general, the higher the LAP, the lower the ejection fraction from the left ventricle. 5-12 mm Hg
Pulmonary artery pressure (PAP)
PA systolic (PAS)
PA diastolic (PAD)
PAP mean (PAPm)
Pulsatile pressure in the pulmonary artery measured by an indwelling catheter. PAS 20-30 mm Hg
PAD 5-10 mm Hg
PAPm 10-15 mm Hg
Pulmonary artery occlusion pressure (PAOP)* Pressure created by the volume in the left side of the heart. When the mitral valve is open, the PAOP reflects filling pressures in the pulmonary vasculature, and pressures in the left side of the heart are transmitted back to the catheter “wedged” into a small pulmonary arteriole. 5-12 mm Hg
Cardiac output (CO) Amount of blood pumped out by a ventricle over 1 minute. Clinically, it can be measured using the thermodilution CO method, which calculates CO in liters per minute (L/min). 4-6 L/min (at rest)
Cardiac index (CI) CO divided by the body surface area (BSA), with tailoring of CO to individual body size. A BSA conversion chart is necessary to calculate CI, which is considered more accurate than CO because it is individualized to height and weight. CI is measured in liters per minute per square meter of BSA (L/min/m2). 2.2-4.0 L/min/m2
Stroke volume (SV) Amount of blood ejected by the ventricle with each heartbeat, expressed in milliliters (mL). Hemodynamic monitoring systems calculate SV by dividing cardiac output (CO in L/min) by the heart rate (HR) and then multiplying the answer by 1000 to change liters to milliliters (mL). 60-70 mL
Stroke volume index (SI) SV indexed to the BSA. 40-50 mL/m2
Systemic vascular resistance (SVR) Mean pressure difference across the systemic vascular bed divided by blood flow. Clinically, SVR represents the resistance against which the left ventricle must pump to eject its volume. This resistance is created by the systemic arteries and arterioles. As SVR increases, CO falls. SVR is measured in Wood units or dyn·sec·cm−5. If the number of Wood units is multiplied by 80, the value is converted to dyn·sec·cm−5. 10-18 Wood units or
800-1400 dyn·sec·cm−5
Systemic vascular resistance index (SVRI) SVR indexed to BSA. 2000-2400 dyn·sec·cm−5
Pulmonary vascular resistance (PVR) Mean pressure difference across pulmonary vascular bed divided by blood flow. Clinically, PVR represents the resistance against which the right ventricle must pump to eject its volume. This resistance is created by the pulmonary arteries and arterioles. As PVR increases, the output from the right ventricle decreases. PVR is measured in Wood units or dyn·sec·cm−5. PVR is normally one sixth of SVR. 1.2-3.0 Wood units or
100-250 dyn·sec·cm−5
Pulmonary vascular resistance index (PVRI) PVR indexed to BSA. 225-315 dyn·sec·cm−5/m2
Left cardiac work index (LCWI) Amount of work the left ventricle does each minute when ejecting blood. The hemodynamic formula represents pressure generated (MAP) multiplied by volume pumped (CO). A conversion factor is used to change mm Hg to kilogram-meter (kg-m). LCWI is always represented as an indexed volume (BSA chart). LCWI increases or decreases because of changes in pressure (MAP) or volume pumped (CO). 3.4–4.2 kg-m/m2
Left ventricular stroke work index (LVSWI) Amount of work the left ventricle performs with each heartbeat. The hemodynamic formula represents pressure generated (MAP) multiplied by volume pumped (SV). A conversion factor is used to change mL/mm Hg to gram-meter (g-m). LVSWI is always represented as an indexed volume. LVSWI increases or decreases because of changes in the pressure (MAP) or volume pumped (SV). 50-62 g-m/m2
Right cardiac work index (RCWI) Amount of work the right ventricle performs each minute when ejecting blood. The hemodynamic formula represents pressure generated (PAP mean) multiplied by volume pumped (CO). A conversion factor is used to change mm Hg to kilogram-meter (kg-m). RCWI is always represented as an indexed value (BSA chart). Similar to LCWI, the RCWI increases or decreases because of changes in the pressure (PAP mean) or volume pumped (CO). 0.54-0.66 kg-m/m2
Right ventricular stroke work index (RVSWI) Amount of work the right ventricle does each heartbeat. The hemodynamic formula represents pressure generated (PAP mean) multiplied by volume pumped (SV). A conversion factor is used to change mm Hg to gram-meter (g-m). RVSWI is always represented as an indexed value (BSA chart). Similar to LVSWI, the RVSWI increases or decreases because of changes in the pressure (PAP mean) or volume pumped (SV). 7.9-9.7 g-m/m2

*Pulmonary artery occlusion pressure (PAOP) was formerly called pulmonary capillary wedge pressure (PCW or PCWP) or pulmonary arterial wedge pressure (PAWP).

Perfusion Pressure. 

A MAP greater than 60 mm Hg is necessary to perfuse the coronary arteries. A higher MAP may be required to perfuse the brain and the kidneys. A MAP between 70 and 90 mm Hg is ideal for the cardiac patient to decrease left ventricular (LV) workload. After a carotid endarterectomy or neurosurgery, a MAP of 90 to 110 mm Hg may be more appropriate to increase cerebral perfusion pressure. Systolic and diastolic pressures are monitored in conjunction with the MAP as a further guide to the accuracy of perfusion. If CO decreases, the body compensates by constricting peripheral vessels to maintain the blood pressure. In this situation, the MAP may remain constant but the pulse pressure (difference between systolic and diastolic pressures) narrows. The following examples explain this point:

Mr. A: BP, 90/70 mm Hg; MAP, 76 mm Hg

Mr. B: BP, 150/40 mm Hg; MAP, 76 mm Hg

Both patients have a perfusion pressure of 76 mm Hg, but they are clinically very different. Mr. A is peripherally vasoconstricted, as is demonstrated by the narrow pulse pressure (90/70 mm Hg). His skin is cool to touch, and he has weak peripheral pulses. Mr. B has a wide pulse pressure (150/40 mm Hg), warm skin, and normally palpable peripheral pulses. Nursing assessment of the patient with an arterial line includes comparison of clinical findings with arterial line readings, including perfusion pressure and MAP.

Pulse Pressure. 

A clinical example of hemodynamic nursing assessment can be seen in patient JW 1 day after coronary artery bypass grafting (CABG). JW recently has been weaned from dopamine (Intropin) and sodium nitroprusside (Nipride) and received an IV diuretic, 20 mg of furosemide (Lasix). He has voided 800 mL of urine via the urinary catheter during the past 2 hours. JW’s MAP remains at 80 mm Hg, but his pulse pressure has narrowed by 30 mm Hg from 120/60 to 100/70 mm Hg. His heart rate (HR) has increased from 90 to 110 beats per minute. This clinical situation is not uncommon after furosemide administration, but the narrowed pulse pressure and increased HR may indicate hypovolemia. The nurse caring for JW will monitor the trend of the MAP. If the MAP begins to decrease and JW shows signs of a low CO, his physician will be notified. In most nonemergency situations, following the trend of the arterial pressure is more valuable than an isolated measurement.

Cuff Blood Pressure. 

If the arterial line becomes unreliable or dislodged, a cuff pressure can be used as a reserve system.10 In the normotensive, normovolemic patient, little difference exists between the arm cuff blood pressure and the intravascular catheter pressure, and differences of 5 to 10 mm Hg do not generally alter clinical management. The situation is different if the patient has a low CO or is in shock. The concern is that the cuff pressure may be unreliable because of peripheral vasoconstriction, and an arterial line is generally required. It is usual practice to compare a cuff pressure after the arterial line is inserted. A recent study in hypotensive patients found that a MAP calculated from the arm cuff blood pressure was comparable to the intravascular arterial MAP.11 However, blood pressure cuffs placed on the thigh or ankle were less accurate in hypotensive patients.11

Arterial Pressure Waveform Interpretation

As the aortic valve opens, blood is ejected from the left ventricle and is recorded as an increase of pressure in the arterial system. The highest point recorded is called systole. After peak ejection (systole), the force decreases, and the pressure drops. A notch (dicrotic notch) may be visible on the downstroke of this arterial waveform, representing closure of the aortic valve. The dicrotic notch signifies the beginning of diastole. The remainder of the downstroke represents diastolic runoff of blood flow into the arterial tree. The lowest point recorded is called diastole. A normal arterial pressure tracing is shown in Figure 14-2. Notice that electrical stimulation (QRS) is always first and that the arterial pressure tracing follows the initiating QRS.

Decreased Arterial Perfusion. 

Specific problems with heart rhythm can translate into poor arterial perfusion if CO decreases. Poor perfusion may be seen as a single, nonperfused beat after a premature ventricular contraction (PVC) (Fig. 14-3) or as multiple, nonperfused beats (Fig. 14-4). In ventricular bigeminy, every second beat is poorly perfused (Fig. 14-5). A disorganized atrial baseline resulting from atrial fibrillation creates a variable arterial pulse because of the differences in stroke volume (SV) between each beat (Fig. 14-6). All of these examples illustrate that when two beats are close together, the left ventricle does not have time to fill adequately, and the second beat is inadequately perfused or is not perfused at all.

Pulse Deficit. 

A pulse deficit occurs when the apical HR and the peripheral pulse are not equal. In the critical care unit, this can be seen on the bedside monitor. Normally, there is one arterial upstroke for each QRS, and if there are more QRS complexes than arterial upstrokes, a pulse deficit is present, as shown in Figures 14-3 and 14-6. To identify a pulse deficit in an unmonitored patient, a stethoscope is placed over the apex of the heart. The heartbeat can be heard, but it cannot be felt as a radial pulse. To determine whether a pulse deficit is significant, it is necessary to evaluate the clinical impact on the patient and whether any change in MAP or pulse pressure has occurred. Generally, the more nonperfused beats, the more serious the problem.

Pulsus Paradoxus. 

Pulsus paradoxus is a decrease of more than 10 mm Hg in the arterial waveform that occurs during inhalation (inspiration). It is caused by a fall in CO as a result of increased negative intrathoracic pressure during inhalation. As pressure within the thorax falls, blood pools in the large veins of the lungs and thorax, and SV is decreased. The procedure for identification of pulsus paradoxus is discussed in Chapter 13 (see Box 13-9).

In certain clinical conditions, the pulsus paradoxus is obvious and can be clearly seen on an arterial waveform. It can be used as a clinical diagnostic test in a patient with cardiac tamponade, pericardial effusion, or constrictive pericarditis.12 Pulsus paradoxus commonly occurs in hypovolemic surgical patients who are mechanically ventilated with large tidal volumes (see Fig. 14-3).

Damped Waveform. 

If the arterial monitor shows a low blood pressure, it is the responsibility of the nurse to determine whether it is a patient problem or a problem with the equipment, as described in Table 14-2. A low arterial blood pressure waveform is shown in Figure 14-7. In this case, the digital readout correlated well with the patient’s cuff pressure, confirming that the patient was hypotensive. This arterial waveform is more rounded, without a dicrotic notch, compared with the normal waveform in Figure 14-2. A damped (flattened) arterial waveform is shown in Figure 14-8. In this case, the patient’s cuff pressure was significantly higher than the digital readout, representing a problem with equipment. A damped waveform occurs when communication from the artery to the transducer is interrupted and produces false values on the monitor and oscilloscope. Damping is caused by a fibrin “sleeve” that partially occludes the tip of the catheter, by kinks in the catheter or tubing, or by air bubbles in the system. Troubleshooting techniques (see Table 14-2) are used to find the origin of the problem and to remove the cause of damping.

TABLE 14-2

NURSING MEASURES TO ENSURE PATIENT SAFETY AND TO TROUBLESHOOT PROBLEMS WITH HEMODYNAMIC MONITORING EQUIPMENT

PROBLEM PREVENTION RATIONALE TROUBLESHOOTING
Overdamping of waveform Provide continuous infusion of solution containing heparin through an in-line flush device (1 unit of heparin for each 1 mL of flush solution). Ensure that recorded pressures and waveform are accurate because a damped waveform gives inaccurate readings. Before insertion, completely flush the line and/or catheter. In a line attached to a patient, back flush through the system to clear bubbles from tubing or transducer.
Underdamping (“overshoot” or “fling”) Use short lengths of noncompliant tubing. Use fast-flush square wave test to demonstrate optimal system damping. Verify arterial waveform accuracy with the cuff blood pressure. If the monitoring system is underdamped, the systolic and diastolic values will be overestimated by the waveform and the digital values. False high systolic values may lead to clinical decisions based on erroneous data. Perform the fast-flush square wave test to verify optimal damping of the monitoring system.
Clot formation at end of the catheter Provide continuous infusion of solution containing heparin through an in-line flush device (1 unit of heparin for each 1 mL of flush solution). Any foreign object placed in the body can cause local activation of the patient’s coagulation system as a normal defense mechanism. The clots that are formed may be dangerous if they break off and travel to other parts of the body. If a clot in the catheter is suspected because of a damped waveform or resistance to forward flush of the system, gently aspirate the line using a small syringe inserted into the proximal stopcock. Flush the line again after the clot is removed, and inspect the waveform. It should return to a normal pattern.
Hemorrhage Use Luer-Lock (screw) connections in line setup. Close and cap stopcocks when not in use.
Ensure that the catheter is sutured or securely taped in position.
A loose connection or open stopcock creates a low-pressure sump effect, causing blood to back into the line and into the open air. If a catheter is accidentally removed, the vessel can bleed profusely, especially with an arterial line or if the patient has abnormal coagulation factors (resulting from heparin in the line) or has hypertension. After a blood leak is recognized, tighten all connections, flush the line, and estimate blood loss.
If the catheter has been inadvertently removed, put pressure on the cannulation site. When bleeding has stopped, apply a sterile dressing, estimate blood loss, and inform the physician. If the patient is restless, an armboard may protect lines inserted in the arm.
Air emboli Ensure that all air bubbles are purged from a new line setup before attachment to an indwelling catheter.
Ensure that the drip chamber from the bag of flush solution is more than one half full before using the in-line, fast-flush system.
Some sources recommend removing all air from the bag of flush solution before assembling the system.
Air can be introduced at several times, including when central venous pressure (CVP) tubing comes apart, when a new line setup is attached, or when a new CVP or pulmonary artery (PA) line is inserted. During insertion of a CVP or PA line, the patient may be asked to hold his or her breath at specific times to prevent drawing air into the chest during inhalation.
The in-line, fast-flush devices are designed to permit clearing of blood from the line after withdrawal of blood samples.
If the chamber of the intravenous tubing is too low or empty, the rapid flow of fluid will create turbulence and cause flushing of air bubbles into the system and into the bloodstream.
Because it is impossible to get the air back after it has been introduced into the bloodstream, prevention is the best cure.
If air bubbles occur, they must be vented through the in-line stopcocks and the drip chamber must be filled.
The left atrial pressure (LAP) line setup is the only system that includes an air filter specifically to prevent air emboli.
Normal waveform with low digital pressure Ensure that the system is calibrated to atmospheric pressure. To provide a 0 baseline relative to atmospheric pressure. Recalibrate the equipment if transducer drift has occurred.
  Ensure that the transducer is placed at the level of the phlebostatic axis. If the transducer has been placed higher than the phlebostatic level, gravity and the lack of hydrostatic pressure will produce a false low reading. Reposition the transducer at the level of the phlebostatic axis. Misplacement can occur if the patient moves from the bed to the chair or if the bed is placed in a Trendelenburg position.
Normal wave form with high digital pressure Ensure that the system is calibrated to atmospheric pressure.
Ensure that the transducer is placed at the level of the phlebostatic axis.
To provide a 0 baseline relative to atmospheric pressure.
If the transducer has been placed lower than the phlebostatic level, the weight of hydrostatic pressure on the transducer will produce a false high reading.
Recalibrate the equipment if transducer drift has occurred.
Reposition the transducer at the level of the phlebostatic axis.
This situation can occur if the head of the bed was raised and the transducer was not repositioned. Some centers require attachment of the transducer to the patient’s chest to avoid this problem.
Loss of waveform Always have the hemodynamic waveform monitored so that changes or loss can be quickly noted. The catheter may be kinked, or a stopcock may be turned off. Check the line setup to ensure that all stopcocks are turned in the correct position and that the tubing is not kinked. Sometimes, the catheter migrates against a vessel wall, and having the patient change position restores the waveform.

image

Underdamped Waveform. 

Another cause of arterial waveform distortion is underdamping, also called overshoot or fling. Underdamping is recognized by a narrow, upward systolic peak that produces a falsely high systolic reading compared with the patient’s cuff blood pressure, as shown in Figure 14-9. The overshoot is caused by an increase in dynamic response or increased oscillations within the system.

Fast-Flush Square Waveform Test. 

The monitoring system’s dynamic response can be verified for accuracy at the bedside by the fast-flush square waveform test, also called the dynamic frequency response test.5 The nurse performs this test to ensure that the patient pressures and waveform shown on the bedside monitor are accurate.5 The test makes use of the manual flush system on the transducer. Normally, the flush device allows only 3 mL of fluid/hr. With the normal waveform displayed, the manual fast-flush procedure is used to generate a rapid increase in pressure, which is displayed on the monitor oscilloscope. As shown in Figure 14-10, the normal dynamic response waveform shows a square pattern with one or two oscillations before the return of the arterial waveform. If the system is overdamped, a sloped (rather than square) pattern is seen. If the system is underdamped, additional oscillations—or vibrations—are seen on the fast-flush square wave test. This test can be performed with any hemodynamic monitoring system. If air bubbles, clots, or kinks are in the system, the waveform becomes damped, or flattened, and this is reflected in the square waveform result.

This is an easy test to perform, and it should be incorporated into nursing care procedures at the bedside when the hemodynamic system is first set up, at least once per shift, after opening the system for any reason, and when there is concern about the accuracy of the waveform.5 If the pressure waveform is distorted or the digital display is inaccurate, the troubleshooting methods described in Table 14-2 can be implemented. The nurse caring for the patient with an arterial line must be able to assess whether a low MAP or narrowed perfusion pressure represents decreased arterial perfusion or equipment malfunction. Assessment of the arterial waveform on the oscilloscope, in combination with clinical assessment, and use of the square waveform test will yield the answer.

Alarms. 

All critically ill patients must have the hemodynamic monitoring alarms on and adjusted to sound an audible alarm if the patient should experience a change in blood pressure, HR, respiratory rate, or other significant monitored variable. The key issues concerning monitor alarms are presented in Box 14-2.

image Box 14-2   Patient Safety Alert

Clinical Alarm Systems

Clinical Alarm Safety

Central Venous Pressure Monitoring

Indications

CVP monitoring is indicated whenever a patient has significant alteration in fluid volume (see Table 14-1). The CVP can be used as a guide in fluid volume replacement in hypovolemia and to assess the impact of diuresis after diuretic administration in the case of fluid overload. When a major intravenous line is required for volume replacement, a CVC is a good choice because large volumes of fluid can easily be delivered.

Central Venous Catheters

A range of CVC options are available as single-, double-, triple-, and quad-lumen infusion catheters, depending on the specific needs of the patient. CVCs are made from a variety of materials ranging from polyurethane to silicone; most are soft and flexible. Catheters that are antimicrobial-impregnated or heparin-coated have a lower rate of bloodstream infections.4

Insertion. 

The large veins of the upper thorax—subclavian (SC) and internal jugular (IJ)—are most commonly used for percutaneous CVC line insertion.4 The femoral vein in the groin is used when the thoracic veins are not accessible. All three major sites have advantages and disadvantages.

Internal Jugular Vein. 

The IJ vein is the most frequently used access site for CVC insertion. Compared with the other thoracic veins, it is the easiest to canalize. If the IJ vein is not available, the external jugular (EJ) vein may be accessed, although blood flow is significantly higher in the IJ vein, making it the preferred site. Another advantage of the IJ vein is that the risk of creating an iatrogenic pneumothorax is small. Disadvantages to the IJ vein are patient discomfort from the indwelling catheter when moving the head or neck and contamination of the IJ vein site from oral or tracheal secretions, especially if the patient is intubated or has a tracheostomy. This may be the reason why catheter-related infections are higher in the IJ than the SC position for indwelling catheters left in place for more than 4 days.13,14

Femoral Vein. 

The femoral vein is considered the easiest cannulation site because there are no curves in the insertion route. The large diameter of the femoral vein carries a high blood flow that is advantageous for specialized procedures such as continuous renal replacement therapy (CRRT) or plasmapheresis. Because there is a higher rate of nosocomial infection with femoral catheters, this site is not recommended.4 If a femoral venous access has been used, the CVC should be changed to either the SC or IJ location as soon as the patient is hemodynamically stable.4

During insertion of a catheter in the SC or IJ vein, the patient may be placed in a Trendelenburg position. Placing the head in a dependent position causes the IJ veins in the neck to become more prominent, facilitating line placement. To minimize the risk of air embolus during the procedure, the patient may be asked to “take a deep breath and hold it” any time the needle or catheter is open to air. The tip of the catheter is designed to remain in the vena cava and should not migrate into the right atrium. Because many patients are awake and alert when a CVC is inserted, a brief explanation about the procedure can minimize patient anxiety and result in cooperation during the insertion. This cooperation is important, because CVC insertion is a sterile procedure and because the supine or Trendelenburg position may not be comfortable for many patients. The electrocardiogram (ECG) should be monitored during CVC insertion because of the associated risk of dysrhythmias.

All central catheters are designed for placement by percutaneous injection after skin preparation and administration of a local anesthetic. Visualization of the vessel with a bedside ultrasound before insertion is recommended to reduce the number of CVC placement attempts.4 A prepackaged CVC kit typically is used for the procedure. The standard CVC kit contains sterile towels, chlorhexidine and alcohol for skin preparation, a needle introducer, a syringe, guidewire, and a catheter. The Seldinger technique, in which the vein is located by using a “seeking” needle and syringe, is the preferred method of placement. A guidewire is passed through the needle, the needle is removed, and the catheter is passed over the guidewire. After the tip of the catheter is correctly placed in the vena cava, the guidewire is removed. A sterile intravenous tubing and solution is attached, and the catheter is sutured in place. Following upper thoracic CVC placement, a chest radiograph is obtained to verify placement and the absence of an iatrogenic hemothorax or pneumothorax, especially if the SC vein was accessed.

Central Venous Catheter Complications

The CVC is an essential tool in care of the critically ill patient, but it is associated with some risks, and it is the responsibility of all clinicians to be informed about these hazards and to follow hospital procedures to avoid iatrogenic complications. CVC complications include air embolus, catheter-associated thrombus formation, and infection.

Air Embolus. 

The risk of air embolus, although uncommon, is always present for the patient with a central venous line in place. Air can enter during insertion15 through a disconnected or broken catheter by means of an open stopcock, or air can enter along the path of a removed CVC.16,17 This is more likely if the patient is in an upright position, because air can be pulled into the venous system with the increase in negative intrathoracic pressure during inhalation. If a large volume of air is infused rapidly, it may become trapped in the right ventricular outflow tract, stopping blood flow from the right side of the heart to the lungs. Based on animal studies, this volume is approximately 4 mL/kg.18 If the air embolus is large, the patient will experience respiratory distress and cardiovascular collapse. An auscultatory clinical sign specifically associated with a large venous air embolism is the mill wheel murmur.15,16,19 A mill wheel murmur is a loud, churning sound heard over the middle chest, caused by the obstruction to right ventricular outflow. Treatment involves immediately occluding the external site where air is entering, administering 100% oxygen, and placing the patient on the left side with the head downward (left lateral Trendelenburg position).19 This position displaces the air from the right ventricular outflow tract to the apex of the heart, where the air may be aspirated by catheter intervention or gradually absorbed by the bloodstream as the patient remains in the left lateral Trendelenburg position. Precautions to prevent an air embolism in a CVP line include using only screw (Luer-Lock) connections, avoiding long loops of intravenous tubing, and using closed-top screw caps on the three-way stopcock.

Thrombus Formation. 

Clot formation (thrombus) at the CVC site is unfortunately common. Thrombus formation is not uniform; it may involve development of a fibrin sleeve around the catheter,20 or the thrombus may be attached directly to the vessel wall. Other factors that promote clot formation include rupture of vascular endothelium, interruption of laminar blood flow, and physical presence of the catheter, all of which activate the coagulation cascade. The risk of thrombus formation is higher if insertion was difficult or there were multiple needlesticks. Gradual thrombus formation may lead to “sudden” CVC occlusion. Usually, the CVC becomes more difficult to withdraw blood from, or the CVP waveform becomes intermittently damped over a period of hours or even 1 to 2 days and is reported as “needing frequent flushes” to remain patent. This situation is caused by the continued lengthening of a fibrin sleeve that extends along the catheter length from the insertion site past the catheter tip.20 Some catheters are heparin coated to reduce the risk of thrombus formation, although the risk of HIT does not make this a benign option. Sometimes, CVC complications are additive; for example, the risk of catheter-related infection is increased in the presence of thrombi, where the thrombus likely serves as a culture medium for bacterial growth. Because of concerns over the development of HIT many hospitals use a saline-only flush to maintain CVC patency.21,22

Infection. 

Infection related to the use of CVCs is a major problem. The incidence of infection strongly correlates with the length of time the CVC has been inserted, longer insertion times leading to a higher infection rate.4,23 CVC-related infection is identified at the catheter insertion site or as a bloodstream infection (septicemia). Systemic manifestations of infection can be present without inflammation at the catheter site. No decrease in bloodstream infections was found when catheters were routinely changed and this practice is no longer recommended.4 When a CVC is infected it must be removed and a new catheter inserted in a different site. If a catheter infection is suspected, the CVC should not be changed over a guidewire because of the risk of transferring the infection.4 Most infections are transmitted from the skin, and infection prevention begins prior to insertion of the CVC. Insertion guidelines state that the physician must use effective hand-washing procedures, clean the insertion site with 2% chlorhexidine gluconate in 70% isopropyl, use sterile technique during catheter insertion, and maintain maximal sterile barrier precautions.4 In many hospitals the nurse is authorized to stop the procedure if these insertion infection control guidelines are not followed. A daily review to determine whether the catheter is still required is recommended to ensure CVCs are removed promptly when no longer needed (Box 14-3).4

image Box 14-3

Patient Safety Alert

Prevention of Central Venous Catheter-Related Bloodstream Infections

image

1. Education, Training, and Staffing

2. Selection of Catheters and Sites

3. Hand Hygiene and Aseptic Technique

4. Maximal Sterile Barrier Precautions

5. Skin Preparation

6. Catheter Site Dressing Regimens

7. Patient Cleansing

8. Catheter Securement Device

9. Antimicrobial Strategies

10. No Routine CVC Replacement

O’Grady P, et al. Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control. 2011;39(4):S1-S34.

All clinicians must use good hand-washing technique and follow aseptic procedures during site care and any time the CVC system is entered to withdraw blood, give medications, or change tubing.4 Site dressings impregnated with chlorhexidine are recommended to lower CVC infection rates.4

Nursing Management

In the critically ill patient, the CVC is used to monitor the CVP and waveform. The CVP catheter is used to measure the filling pressures of the right side of the heart. During diastole, when the tricuspid valve is open and blood is flowing from the right atrium to the right ventricle, the CVP accurately reflects right ventricular end-diastolic pressure (RVEDP). The normal CVP is 2 to 5 mm Hg (3 to 8 cm H2O).

Central Venous Pressure—Volume Assessment. 

The time-honored practice of using the CVP value to assess central volume status has now been challenged.24 A landmark systematic review of the literature revealed a weak relationship between the CVP measurement and blood volume.24 Nor was a low CVP value always reliable in predicting who would respond to a fluid challenge.24 In patients with a CVP between 0 and 5 mm Hg, up to 25% do not respond to a fluid challenge as expected.25 Overall only about half of critically ill patients respond as expected to a fluid challenge.24 In this situation the clinician must look at other indices of poor tissue perfusion such as an elevated lactate level, low base deficit, or decreased urine output.25

Water Versus Mercury Central Venous Pressure. 

CVP values are measured in millimeters of mercury (mm Hg) if bedside hardwire monitoring is used. If a patient is admitted from a medical–surgical unit with a water manometer CVP and clinicians want to know the relationship between the two values, it involves a straightforward calculation based on the following standard relationship: 1 mm Hg (mercury pressure) is equivalent to 1.36 cm H2O (water pressure). Although the numeric value in cm H2O will be higher, the values are clinically equivalent for the specific patient. To convert water manometer pressure to mercury pressure, the water-pressure value is divided by 1.36 (H2O ÷ 1.36). To convert mercury pressure to water pressure, the mercury value is multiplied by 1.36 (mm Hg × 1.36).

Removal. 

Removal of the CVC usually is a nursing responsibility. Complications are infrequent, and the ones to anticipate are bleeding and air embolus. Recommended techniques to avoid air embolus during CVC removal include removing the catheter when the patient is supine in bed (not in a chair) and placing the patient flat or in reverse Trendelenburg position if the patient’s clinical condition permits this maneuver. Patients with heart failure, pulmonary disease, and neurologic conditions with raised intracranial pressure (ICP) should not be placed flat. If the patient is alert and able to cooperate, he or she is asked to take a deep breath to raise intrathoracic pressure during removal. After removal, to decrease the risk of air entering by a “track,” an occlusive dressing is applied to the site. If bleeding at the site occurs after removal, firm pressure is applied. If a patient has prolonged coagulation times, fresh-frozen plasma or platelets may be prescribed before CVC removal.

Central Venous Pressure Waveform Interpretation. 

The normal right atrial (CVP) waveform has three positive deflections—a, c, and v waves—that correspond to specific atrial events in the cardiac cycle (Fig. 14-11). The a wave reflects atrial contraction and follows the P wave seen on the ECG. The downslope of this wave is called the x descent and represents atrial relaxation. The c wave reflects the bulging of the closed tricuspid valve into the right atrium during ventricular contraction; this wave is small and not always visible but corresponds to the QRS-T interval on the ECG. The v wave represents atrial filling and increased pressure against the closed tricuspid valve in early diastole. The downslope of the v wave is named the y descent and represents the fall in pressure as the tricuspid valve opens and blood flows from the right atrium to the right ventricle.

Cannon Waves. 

Dysrhythmias can change the pattern of the CVP waveform. In a junctional rhythm or after a PVC, the atria are depolarized after the ventricles if retrograde conduction to the atria occurs. This may be seen as a retrograde P wave on the ECG and as a large combined ac or cannon wave on the CVP waveform (Fig. 14-12). These cannon waves can be easily detected as large pulses in the jugular veins. Other pathologic conditions, such as advanced right ventricular failure or tricuspid valve insufficiency, allow regurgitant backflow of blood from the right ventricle to the right atrium during ventricular contraction, producing large v waves on the right atrial waveform. In atrial fibrillation, the CVP waveform has no recognizable pattern because of the disorganization of the atria.

Pulmonary Artery Pressure Monitoring

The pulmonary artery (PA) catheter is the most invasive of the critical care monitoring catheters. It is also known as a right heart catheter or Swan-Ganz catheter (named after the catheter’s inventors). The practice of routinely using PA catheters is highly controversial. Several randomized, controlled trials of critically ill patients have not demonstrated a benefit to use of the PA catheter. A randomized, controlled trial of 676 critical care patients with acute respiratory distress syndrome (ARDS) in France reported no difference in mortality rates for patients when treatment was guided by PA catheter and for patients without this information.28 A randomized, controlled trial of 1000 patients with ARDS in the United States found no difference in mortality rates for patients when treatment was guided by a PA catheter and those for whom diagnostic information was obtained from a CVP.29

The impact of PA catheterization on mortality rates for patients with acute heart failure has also been examined. A randomized, controlled trial of 433 patients with acute heart failure in the United States reported no difference in mortality based on whether fluid volume management was guided by PA catheter insertion or not.30 Similar results were reported from a British multicenter trial enrolling more than 1000 critical care patients; there were no differences in mortality or in length of stay.31 No survival benefit was found in a randomized, controlled trial enrolling older high-risk surgical patients who required critical care monitoring when treatment was guided by PA catheter diagnostics or not.32 Systematic reviews and meta-analysis of studies of PA catheter use have reached similar conclusions—that insertion of a PA catheter is neutral, it neither conferred a benefit nor increased risk to the patient. There was no increase in mortality or increase in the number of days in the critical care unit or the hospital.33,34

These findings have raised concerns about routine use of PA catheters for critically ill patients. The PA catheter is invasive. It previously seemed intuitive that the diagnostic information provided would confer a survival advantage over less invasive methods, but research has shown this is not the case. Consequently PA catheter use has decreased dramatically. The number of PA catheters inserted in the United States has declined by 65% over 10 years (1993-2004).35 In western Canada the decline in PA catheter use was 50% over 5 years (2002-2006).36

Although the PA catheter is inserted less frequently in critical care units, right heart catheterization is still used as a diagnostic tool in the cardiac catheterization laboratory. In many critical care units, the PA catheter is reserved for patients who are refractory to conventional treatment,37 and in many settings, it has been replaced by less invasive technologies such as echocardiography, as discussed later in this chapter.

Indications

The thermodilution PA catheter is reserved for the most hemodynamically unstable patients, for the diagnosis and evaluation of heart disease,38 and shock states. The PA catheter is used to evaluate patient response to treatment, as described in Table 14-3. The PA catheter can simultaneously assess PA systolic and diastolic pressures, PA mean pressure, and PAOP (wedge pressure). The PA catheter is used to measure CO, determine mixed venous oxygen saturation, and calculate additional hemodynamic parameters.

TABLE 14-3

PULMONARY ARTERY CATHETERS: SELECTED INDICATIONS FOR USE AND RESPONSE TO TREATMENT

DIAGNOSTIC INDICATIONS* POSSIBLE CAUSE ASSOCIATED CLINICAL FINDINGS HEMODYNAMIC PROFILE TREATMENT AND EXPECTED RESPONSE
Hypovolemic shock Trauma
Surgery
Bleeding
Burns
Excessive diuresis
Cardiovascular: sinus tachycardia, ↓ BP (SBP <90 mm Hg), weak peripheral pulses
Pulmonary: lungs clear
Renal: ↓ urinary output
Skin: normal skin temperature, no edema
Neurologic: variable
Low CO
Low CI (2.2 L/min/m2)
High SVR (>1600 dyn·sec·cm−5)
Low PAP
Low PAOP
Treatment:
Fluid challenge
Expected hemodynamic response:
 ↓ HR
 ↑ BP
 ↑ PAP
 ↑ PAOP
 ↑ CVP
 ↑ CO/CI
 ↓ SVR
Septic shock Sepsis Cardiovascular: sinus tachycardia, ↓ BP (SBP <90 mm Hg), bounding peripheral pulses
Pulmonary: lungs may be clear or congested, depending on the origin of the sepsis
Renal: ↓ urinary output
Skin: warm and flushed
Neurologic: variable
High CO (>8 L/min)
High CI
Low SVR (<600 dyn·sec·cm−5)
Low PAP
Low PAOP
Low CVP
Treatment: IV fluid to maintain hemodynamic function
Fluid challenge
Peripheral vasoconstricting agent (alpha) to ↑ SVR
        Antibiotics and laboratory cultures to find site of infection
        Consider rhAPC
        Expected hemodynamic response:
         ↓ HR
         ↑ BP
         ↑ PAP
         ↑ PAOP
         ↑ CVP
         ↑ CO and CI
         ↑ SVR
         Svo2 = 70%
Multisystem failure shock Multiple organ dysfunction syndrome (MODS) Cardiovascular: normal sinus rhythm or sinus tachycardia,
↓ BP, weak peripheral pulses
Pulmonary: lungs may be clear or congested, depending on the site of sepsis; acidosis based on arterial blood gas values, may require mechanical ventilation
Renal: ↓ urinary output, may have ↑ BUN and ↑ creatinine levels
Skin: cool and mottled
Low CO
Low CI (<2.2 L/min/m2)
High SVR (>1600 dyn·sec·cm−5)
High or low PAP
High or low PAOP
High or low CVP
Treatment: Vasodilators to ↓ SVR, Antibiotics
Support of body system as necessary (e.g., mechanical ventilation, hemodialysis)
    Neurologic: variable, depending on fluid status and medications used in treatment   Expected hemodynamic response:
 ↓ HR
 ↑ BP
 Normalized PAP, PAOP, CVP
         ↓ SVR
         ↓ PVR
         ↑ CO and CI
Cardiogenic shock LV pump failure caused by acute myocardial infarction or severe mitral or aortic valve disease Cardiovascular: sinus tachycardia, possibly dysrhythmias, systolic BP <90 mm Hg, S3 or S4, weak peripheral pulses
Pulmonary: lungs may have crackles or pulmonary edema
Renal: ↓ urinary output
Skin: cool, pale, and moist
Low CO
Low CI (<2.2 L/min/m2)
High SVR (>1600 dyn·sec·cm−5)
High PAP
High PAOP (>15 mm Hg)
High CVP
Low SVI
Low left CWI
Low left VSWI
Treatment: Inotropic medications to ↑ LV contractility
Vasodilators or IABP to ↓ SVR
Diuretics to ↓ preload
Optimization of HR and control of dysrhythmias
        Expected hemodynamic response:
         ↓ HR
         ↑ BP
         ↓ PAP
         ↓ PAOP
         ↓ CVP
         ↓ SVR
         ↑ CO and CI
         ↑ SVI
         ↑ Left CWI
         ↑ Left VSWI
Acute respiratory distress syndrome (ARDS) or noncardiogenic pulmonary edema Trauma
Sepsis
Shock
Inhaled toxins (smoke, chemicals, 100% oxygen)
Aspiration of gastric contents
Metabolic disorders
Neurologic: may have ↓ mentation caused by low BP and CO
Cardiovascular: sinus tachycardia, high or low BP, normal peripheral pulses
Pulmonary: poor oxygenation and pulmonary edema, ↑ respiratory rate, or need for mechanical ventilation
Renal: ↑ or ↓ urinary output
Skin: normal temperature
Neurologic: anxiety or confusion associated with respiratory distress and poor oxygenation
Normal CO
Normal CI
Normal SVR
Normal PAOP
High PAP
High PVR
(>250 dyn·sec·cm−5)
Low right CWI
Low right VSWI
Treatment: Eliminate cause of ARDS
Support pulmonary function as necessary
Expected hemodynamic response:
 ↓ HR
 Normal BP
 ↓ PAP
 ↓ PVR
 ↑ Right CWI
 ↑ Right VSWI
 Normal CO and CI
 Normal SVR

image

image

BP, Blood pressure; BUN, blood urea nitrogen; CI, cardiac index; CO, cardiac output; CVP, central venous pressure; CWI, cardiac work index; HR, heart rate; IABP, intra-aortic balloon pump; IV, intravenous; PAOP, pulmonary artery occlusion pressure; PAP, pulmonary artery pressure; PVR, pulmonary vascular resistance; rhAPC, recombinant human activated protein C; SBP, systolic blood pressure; SVI, stroke volume index; Svo2, mixed venous oxygen saturation; SVR, systemic vascular resistance; VSWI, ventricular stroke work index; ↓, decrease or decreased; ↑, increase or increased.

*Patients undergoing major vascular or cardiac surgery may also have a pulmonary catheter in situ to follow the trend of the cardiac output and cardiac index, SVR systemic vascular resistance and PVR pulmonary vascular resistance, and fluid status during the first 24 hours after surgery.

See Table 14-1 for definitions and Appendix B for normal values of hemodynamic parameters listed in this table.

Oxygen Supply and Demand

When the peripheral tissues need more oxygen (e.g., during exercise or fever), the normal, healthy heart can augment HR and SV and greatly increase CO. In the critically ill patient, when the tissues require more oxygen, these normal mechanisms are often nonfunctional, and it is the critical care nurse who assesses the need for and then optimizes hemodynamic function. The following discussion is intended to provide a basic understanding of the clinical factors that determine CO and the role of the critical care nurse in caring for the patient with an alteration in any of these factors.

Preload. 

Clinicians commonly describe the hemodynamic numbers related to preload as filling pressures. These values refer to the pressures resulting from the volumes in the atria and ventricles. These pressure numbers include pulmonary artery diastolic pressure (PADP) and PAOP (or wedge pressure), which measure preload in the left side of the heart, and CVP, which measures preload in the right side of the heart.

Preload is the volume in the ventricle at end-diastole. Because diastole is the filling stage of the cardiac cycle, the volume in the ventricle at end-diastole represents the presystolic volume available for ejection for that cardiac cycle. LV volume can be measured directly during cardiac catheterization but it is not generally measured in the critical care unit. The principle is that the presence of blood within the ventricle creates pressures that can be measured by the PA catheter and transducer and can be displayed on the bedside monitor.

Measurement of Preload. 

When the PA catheter is correctly positioned with the tip in one of the large branches of the PA, the only valve between the PA catheter tip and the left ventricle is the mitral valve. During diastole, when the mitral valve is open, no obstruction exists between the tip of the PA catheter and the left ventricle (Fig. 14-14). The LV preload volume creates left ventricular end-diastolic pressure (LVEDP). This is measured clinically by the PAOP or “wedge” pressure. The PAOP and PADP are the values most often referred to in this chapter, because they are the values used in clinical practice. Normal left atrial pressure (LAP) or PAOP is 5 to 12 mm Hg.

Frank-Starling Law of the Heart. 

Clinically the PAOP has significance because a change in LV volume (preload) is reflected by a change in the measured PAOP (wedge pressure). Change in preload relies on the Frank-Starling law of the heart. This concept states that the force of ventricular ejection is directly related to two elements:

If the volume in the left ventricle is low, CO is also suboptimal. If intravenous fluids (volume) are infused, CO increases as LV volume and myocardial fiber stretch increase. This is true up to a point. Past this point, more fluid volume overdistends the ventricle and stretches the myocardial fibers so much that CO decreases. This scenario is seen clinically in the setting of acute heart failure with pulmonary edema. The increased volume in the overdistended left ventricle raises pressure in the left ventricle, left atrium, and pulmonary veins (that drain into the left atrium), and it ultimately raises pulmonary capillary pressures measured as an increased wedge pressure (PAOP). The impact of preload on CO is represented in Figures 14-15 and 14-16, using the Frank-Starling curve as a model.

Cardiac Dysfunction. 

A significant relationship exists between LVEDP and cardiac muscle dysfunction. As a general rule, the higher the pressure inside the left ventricle, the greater the degree of cardiac dysfunction. The pressure rises at end-diastole (end of filling) because the compromised ventricle cannot eject all of the preload blood volume. For example, in a patient with heart failure, the preload volume may be 100 mL. However, the SV ejected may be only 30 mL. The EF in this patient is 30% (normal EF is greater than 50%). The remaining preload volume (70 mL in this example) significantly elevates LV pressures. When the mitral valve opens at the beginning of diastole, the pressure in the left atrium needs to be slightly higher than pressures in the left ventricle to allow filling. The 70 mL remaining in the ventricle produces high LV diastolic pressures. This elevates the left atrial filling pressure and consequently elevates the PAOP (wedge pressure). In this example, the left ventricle is overstretched by excessive preload, and CO therefore is below normal. A plan of care for this patient includes decreasing LV preload through 1) restriction of intravenous and oral fluids; 2) venodilation; and 3) diuresis. The myocardial dysfunction will lead to heart failure symptoms that are discussed further in Chapter 15.

Pulmonary Hypertension. 

Specific clinical conditions can alter the normal PADP/PAOP relationship.39 In ARDS with acute pulmonary hypertension, the pulmonary arterial systolic and diastolic pressures are independently raised above the LV pressures. In this clinical situation the PADP will not accurately reflect function of the left side of the heart. The numeric difference between the PADP and the PAOP value is called a gradient. If a large gradient exists between the PAOP and PADP when the PA catheter is inserted, the patient has pulmonary hypertension (Table 14-4, illustration C).

TABLE 14-4

CLINICAL INTERPRETATION OF PULMONARY ARTERY WAVEFORMS

PA PRESSURE CLINICAL INTERPRETATION WAVEFORM INTERPRETATION*
Pulmonary artery systolic (PAS) pressure PAS pressure reflects the systolic pressure in the pulmonary vasculature. Waveform A is a normal waveform. The elevated values in pulmonary hypertension may be caused by idiopathic sources, some congenital heart defects, or lung disease. A
image

Pulmonary artery diastolic (PAD) pressure In the patient with healthy lung vasculature, PAD pressure reflects left ventricular end-diastolic pressure (LVEDP), as shown in waveform B. Even if the patient experiences heart failure, the pulmonary artery occlusion pressure (PAOP) and PAD increase together. B
image

  In the presence of acute respiratory distress syndrome or pulmonary hypertension, PAD pressure is not an accurate reflection of PAOP, as shown in waveform C. C
image

Mean pulmonary artery pressure (PAP mean or PAPM) PAP mean pressure is used in the calculation of pulmonary vascular resistance (PVR) and pulmonary vascular resistance index (PVRI), as described in Table 14-1. High mean pressures can reflect cardiac or pulmonary disease. Low mean pressures reflect hypovolemia. Waveform D shows PAP mean placement. D
image

Pulmonary artery occlusion pressure (PAOP) or pulmonary artery wedge pressure (PAWP) In the healthy patient, PAOP reflects blood in the left ventricle at end-diastole (LVEDP). The normal PAOP waveform is a left atrial waveform, as shown in waveform E. E
image

  If a patient has mitral valve regurgitation, the v waves are larger than normal, increasing PAOP and possibly not reflecting true LVEDP, as shown in waveform F. PAOP is elevated in many cardiac disease states in which LV function is compromised. PAOP is low in hypovolemic states. F
image

image

*Pressures on the y axis are given in millimeters of mercury (mm Hg).

Heart Failure. 

In failure of the left side of the heart, the PAOP and PADP are elevated and approximately equal (see Table 14-4, illustration B). The heart failure may cause secondary pulmonary hypertension. Over time, the damage to the lung vasculature occurs because of exposure to high LV pressure.

Mitral Regurgitation. 

In patients with mitral regurgitation (MR), the mean PAOP reading is artificially elevated because of abnormal backflow of blood from the left ventricle to the left atrium during systole. This PAOP reading is distinguished by very large v waves on the PAOP (wedge) tracing and may not reflect the true LVEDP (see Table 14-4, illustration F).

The v waves can be dramatically large in some patients. The size of the v wave is related to the amount of MR and to the compliance of the left atrium.40 If the MR is chronic and the left atrium is compliant and can stretch, the v waves may be small. In the setting of acute MR after infarction of a papillary muscle, the noncompliant or stiff atrium contributes to the development of large v waves. Reading the PAOP tracing in the presence of MR is difficult. If the v waves are large (acute MR), they cannot be used to estimate LV preload. If the v wave is small (chronic MR), the mean PAOP or LAP can still estimate LV preload (LVEDP). Echocardiography also is used to confirm the presence of MR.41

Afterload. 

Afterload is defined as the pressure the ventricle generates to overcome the resistance to ejection created by the arteries and arterioles. It is a calculated measurement derived from information obtained from the PA catheter. As a response to increased afterload, ventricular wall tension rises. After a decrease in afterload, wall tension is lowered. The technical name for afterload is systemic vascular resistance (SVR).

Systemic Vascular Resistance and Afterload Reduction. 

Pharmacologic manipulation of SVR to improve cardiac performance is commonly used with the critically ill patient. When the SVR is elevated, continuous infusions of vasodilators, such as sodium nitroprusside (Nipride), or high-dose nitroglycerin (NTG), may be used to reduce SVR.

If the SVR is extremely low (e.g., less than 500 dyn·sec·cm−5), as may occur in sepsis, the CO will be elevated, and MAP will be low. In this situation, volume and vasopressors are infused to increase MAP and the SVR. After adequate volume resuscitation, the Surviving Sepsis Campaign guidelines recommend centrally administered dopamine, which increases MAP by affecting CO, or norepinephrine (Levophed), which increases MAP by vasoconstriction of the peripheral vasculature to increase SVR.42 Frequent assessment of the peripheral circulation is required when medications that increase SVR are used, because excessive vasoconstriction can negatively affect tissue perfusion.

One case can serve as an example. Mr. T had a large anterior wall MI 2 days ago. As a result, he has symptoms of acute heart failure, an elevated SVR of 1840 dyn·sec·cm−5, and a low CO of 2.8 L/min. In a heart with decreased contractility after an acute MI, an SVR measurement above the normal range lowers CO. To optimize Mr. T’s cardiac function, systemic vasodilators (afterload-reducing medications) are infused to lower the SVR into the normal range. After the administration of sodium nitroprusside (1 to 4 mcg/kg/min), Mr. T’s SVR decreased to 970 dyn·sec·cm−5, and his CO increased to 4.1 L/min. In this situation, decreasing the SVR greatly increased the amount of blood ejected from the left ventricle.

For a person with a normal heart without cardiac dysfunction, an elevated SVR may have minimal impact on CO. In summary, the importance of SVR on CO is related to the functional quality of the myocardium. Whether the heart muscle is globally damaged (cardiomyopathy) or regionally damaged (MI), small changes in SVR can produce significant changes in CO.

Pulmonary Vascular Resistance. 

Resistance to ejection from the right side of the heart is estimated by calculating the pulmonary vascular resistance (PVR). The PVR value is normally one sixth of the SVR. Normal PVR is 100 to 250 dyn·sec·cm−5. The formula to calculate PVR is listed in Appendix B. Acute pulmonary hypertension, identified as a mean PA pressure greater than 25 mm Hg, can occur as a sequela of ARDS.43 The acute rise in PVR may cause the right ventricle to fail, although LV pressures generally remain within the normal range. Traditionally, a PA catheter was used to monitor vasodilator therapy and fluid management. However, because research trials have not shown a survival benefit for patients with ARDS who received invasive PA monitoring compared with CVP monitoring, today, a PA catheter is rarely used.28,29 Chronic pulmonary hypertension is associated with chronic elevation of PVR, and in that situation infusions of pulmonary vasodilators are used to decrease PVR.44 A discussion of pharmacologic management of pulmonary hypertension occurs in Chapter 15; see Table 15-12 and Figure 15-22.

Contractility. 

Many factors have an impact on contractility, including preload volume as measured by PAOP, SVR, myocardial oxygenation, electrolyte balance, positive and negative inotropic medications, and the amount of functional myocardium available to contribute to contraction. These factors can have a positive inotropic effect, enhancing contractility, or a negative inotropic effect, decreasing contractility. Significant factors related to contractility that can be measured by the PA catheter include preload filling pressures, SVR, and CO. Additional contractility numbers can be calculated and are displayed in the hemodynamic profile on the bedside monitor. These include left and right ventricular stroke work index values (LVSWI and RVSWI). These values estimate the force of cardiac contraction (see Table 14-1).

Preload has an impact on contractility by means of Starling’s mechanism. As volume in the ventricle rises, contractility increases. If the ventricle is overdistended with volume, contractility falls (see Figs. 14-15 and 14-16). SVR alters contractility by changes in resistance to ventricular ejection. If SVR is high, contractility is decreased. If SVR is low, contractility is augmented. Hypoxemia acts as a negative inotrope. The myocardium must have oxygen available to the cells to contract efficiently.

Pulmonary Artery Catheters

The traditional PA catheter, invented by Swan and Ganz, has four lumens for measurement of right atrial pressure (RAP) or CVP, PA pressures, PAOP, and CO (Fig. 14-17A). Multifunction catheters may have additional lumens, which can be used for intravenous infusion (Fig. 14-17B) and to measure continuous Svo2, right ventricular volume, and continuous CO (Fig. 14-17C). Other PA catheters include transvenous pacing electrodes to pace the heart if needed.

The PA flow directed catheter is 110 cm long. The most commonly used size is 7.5 or 8.0 Fr, although 5.0 and 7.0 Fr sizes are available. Each of the four lumens exits into the heart or PA at a different point, graduated along the catheter length (see Fig. 14-17A).

Additional Features. 

If continuous Svo2 is measured, the catheter has an additional fiberoptic lumen that exits at the tip of the catheter (see Fig. 14-17C). If cardiac pacing is used, two PA catheter methods are available. One type of catheter has three atrial (A) and two ventricular (V) pacing electrodes attached to the catheter so that when it is properly positioned, the patient can be connected to a pacemaker and be AV paced. The other catheter method uses a specific transvenous pacing wire that is passed through an additional catheter lumen and exits into the right ventricle if ventricular pacing is required. A right ventricular volumetric PA catheter is available that measures SV in the right ventricle.

Insertion

If a PA catheter is to be inserted into a patient who is awake, some brief explanations about the procedure are helpful to ensure that the patient understands what is going to happen. The initial insertion techniques used for placement of a PA catheter are similar to those described for CVC insertion. Because the PA catheter is positioned within the heart chambers and PA on the right side of the heart, catheter passage is monitored using fluoroscopy or waveform analysis on the bedside monitor (Fig. 14-18).

Before inserting the catheter into the vein, the physician—using sterile technique—tests the balloon for inflation and flushes the catheter with NS solution to remove any air. The PA catheter is then attached to the bedside hemodynamic line setup and monitor so that the waveforms can be visualized while the catheter is advanced through the right side of the heart (see Fig. 14-18). A larger introducer sheath (8.5 Fr)—which has the tip positioned in the vena cava and has an additional intravenous side-port lumen—is often used to cannulate the vein first. This introducer sheath is known by several different names in clinical practice, including sheath, cordis, introducer, or side port. This introducer sheath remains in place, and the supple PA catheter is threaded through it into the vena cava and into the right side of the heart.

Pulmonary Artery Waveform Interpretation

Each chamber of the heart has a distinctive waveform with recognizable characteristics. It is the responsibility of the critical care nurse to recognize each waveform displayed on the bedside monitor when the catheter enters the corresponding chamber during insertion and during routine monitoring.

Right Atrial Waveform. 

As the PA catheter is advanced into the right atrium during insertion, a right atrial waveform must be visible on the monitor, with recognizable a, c, and v waves (see Fig. 14-18). The normal mean pressure in the right atrium is 2 to 5 mm Hg. Before passage through the tricuspid valve, the balloon at the tip of the catheter is inflated for two reasons. First, it cushions the pointed tip of the PA catheter so that if the tip comes into contact with the right ventricular wall, it will cause less myocardial irritability and, consequently, fewer ventricular dysrhythmias. Second, inflation of the balloon assists the catheter to float with the flow of blood from the right ventricle into the PA. It is because of these features and the balloon that PA catheters are described as flow-directional catheters.

Pulmonary Artery Occlusion Waveform (Wedge). 

While the balloon remains inflated, the catheter is advanced into the wedge position. This maneuver produces the PAOP. The waveform decreases in size and is nonpulsatile, reflecting a normal left atrial tracing with a and v wave deflections. This is known as a wedge tracing, because the balloon is “wedged” into a small pulmonary vessel, but it is technically described as the PAOP (see Fig. 14-18). The balloon occludes the pulmonary vessel so that the PA catheter tip and lumen are exposed only to left atrial pressure (LAP) and are protected from the pulsatile influence of the right ventricle and PA. When the balloon is deflated, the catheter should spontaneously float back into the PA. When the balloon is reinflated, the wedge tracing should be visible. The normal PAOP ranges from 5 to 12 mm Hg.

After insertion, the introducer is sutured to the skin, the catheter, which lies within the introducer, is secured with tape or with a specialized catheter securement device. A chest radiograph is taken to verify placement. If the catheter is advanced too far into the pulmonary bed, the patient is at risk for pulmonary infarction. If the PA catheter is not sufficiently advanced into the PA, it will not be useful for PAOP readings. However, in many critical care units, if the patient’s PADP and PAOP values approximate (within 0 to 3 mm Hg), the PADP is reliably used to follow the trend of LV filling pressure (preload). This prevents possible trauma from frequent balloon inflation; in such a situation, the PA catheter is consciously pulled back into a nonwedging position in the PA.

After insertion of the catheter, the chest radiograph or fluoroscopy is used to verify the PA catheter position to make sure that it is not looped or knotted in the right ventricle and to rule out pneumothorax or hemorrhagic complications. A thin plastic sleeve is placed on the outside of the catheter when it is inserted to maintain sterility of the part of the PA catheter that exits from the patient. If the PA catheter is not in the desired position or if it migrates out of position, it can be repositioned. Use of this external sleeve on PA catheters has been associated with lower rates of bloodstream infection.4

Nursing Management

The more knowledgeable the critical care nurse can become about use of the PA catheter, the more accurate and effective the nursing management interventions will be.5 Factors that affect PA measurement are the head-of-bed backrest position and lateral body position relative to transducer height placement, respiratory variation, and use of positive end-expiratory pressure (PEEP).

Patient Position. 

The patient does not need to be flat for accurate pressure readings to be obtained. In the supine position, when the transducer is placed at the level of the phlebostatic axis, a head-of-bed position from flat up to 60 degrees is appropriate for most patients.5 It is important to know that PADP and PAOP measurements in the lateral position may be significantly different from those taken when the patient is lying supine. If there is concern about the validity of pressure readings in a particular patient, it is more reliable to take measurements with the patient on his or her back, with the head of bed elevated from flat to 60 degrees as tolerated. After a patient changes position, a stabilization period of 5 to 15 minutes is recommended before taking pressure readings.5 The stabilization period is usually longer if the patient has LV dysfunction or is hemodynamically unstable.

Respiratory Variation. 

All PADP and PAOP (wedge) tracings are subject to respiratory interference, especially when the patient is on a positive-pressure, volume-cycled ventilator.5 During the positive-pressure inhalation phase, the increase in intrathoracic pressure may “push up” the PA tracing, producing an artificially high reading (Fig. 14-19A). During inhalation with spontaneous breaths, negative intrathoracic pressure “pulls down” the waveform, producing an erroneously low measurement (see Fig. 14-19B). To minimize the impact of respiratory variation, the PADP is read at end-expiration, which is the most stable point in the respiratory cycle when intrapleural pressures are close to zero. If the digital number fluctuates with respiration, a printed readout on paper can be obtained to verify true PADP. In some clinical settings, ECG signals or airway pressure and flow are recorded simultaneously with the PADP/PAOP tracing to identify end-expiration.5

Positive End-Expiratory Pressure. 

Some clinical diagnoses, such as ARDS, require the use of high levels of PEEP set with the ventilator to treat refractory hypoxemia. If a PEEP of greater than 10 cm H2O is used, PAOP (wedge) and PAPs will be artificially elevated, and CO may be negatively affected. Because of this impact of PEEP, in the past, patients in some critical care units were taken off the ventilator to record PAP measurements. It has since been shown that this practice closes alveoli, decreases the patient’s oxygenation level, and may result in persistent hypoxemia.

Because patients remain on PEEP for treatment, they remain on it during measurement of PAPs. In this situation, the trend of PA readings is more important than one individual measurement. The most important factor is not one individual measurement or the absolute number obtained; it is instead the trend of the measurements being used as a basis for clinical interventions to support and improve cardiopulmonary function in the critically ill.

Avoiding Complications. 

Potential cardiac complications include ventricular dysrhythmias, endocarditis, valvular damage, cardiac rupture, and cardiac tamponade. Potential pulmonary complications include rupture of a PA, PA thrombosis, embolism or hemorrhage, and infarction of a segment of lung. The PA catheter tracing is continuously monitored to ensure that the catheter does not migrate forward into a spontaneous wedge or PAOP position. A segment of lung can suffer infarction if the wedged catheter occludes an arteriole for a prolonged period. If the catheter is spontaneously wedged the catheter must be gently pulled back out of the wedge position to prevent pulmonary infarction.

Infection is always a risk with a PA catheter. The risks are similar to those discussed in the section on CVCs (see Box 14-3).

Pulmonary Artery Catheter Removal. 

PA catheters can be safely removed from the patient by critical care nurses competent in this procedure.5,46 Removal is not usually associated with major complications. Sometimes there are PVCs as the catheter is pulled through the right ventricle.5

Cardiac Output Measurement

The PA catheter measures CO using an intermittent (bolus) or a continuous CO method.

Thermodilution Cardiac Output Bolus Method. 

The bolus thermodilution method is performed at the bedside and results in CO calculated in liters per minute. Three CO values that are within a 10% mean range are obtained at one time and are averaged to calculate CO. A known amount (5 mL) of iced or, more typically, 10 mL of room-temperature NS solution is injected into the proximal lumen of the PA catheter. The injectate exits into the right atrium and travels with the flow of blood past the thermistor (temperature sensor) located at the distal end of the catheter in the PA. The injectate can be delivered by hand injection using individual syringes of saline. Frequently, a closed in-line system attached to a 500-mL bag of NS is used as a reservoir to deliver the individual injections.

Sometimes, the right atrial (proximal) port is clotted and not usable. If another right atrial port is available, it can be substituted. However, if a usable port is not available, to ensure accurate CO data, a new PA catheter is inserted.

Cardiac Output Curve. 

The thermodilution CO method uses the indicator-dilution method, in which a known temperature is the indicator. It is based on the principle that the change in temperature over time is inversely proportional to blood flow. Blood flow can be diagrammatically represented as a CO curve on which temperature is plotted against time (Fig. 14-20A). Most hemodynamic monitors display this CO curve, which must then be interpreted to determine whether the CO injection is valid. The normal curve has a smooth upstroke, with a rounded peak and a gradually tapering down-slope. If the curve has an uneven pattern, it may indicate faulty injection technique, and the CO measurement must be repeated. Patient movement or coughing also alters the CO measurement (see Fig. 14-20B).

Patient Position and Cardiac Output. 

In the normovolemic, stable patient, reliable CO measurements can be obtained in a supine position (patient lying on his or her back) with the head of the bed elevated up to 60 degrees.5 If the patient is hypovolemic or unstable, leaving the head of the bed in a flat position or only slightly elevated is the most clinically appropriate choice. CO measurements performed when the patient is turned to the side are not considered as accurate as those performed with the patient in the supine position.

Calculated Hemodynamic Profiles. 

For the patient with a thermodilution PA catheter in place, additional hemodynamic information can be calculated using routine vital signs, CO, and body surface area (BSA). These measurements are calculated using specific formulas that are indexed to a patient’s body size using the DuBois body area surface chart or the computer program associated with the current generation of hemodynamic monitors.

The calculated values used in the hemodynamic profiles are described in Table 14-1. Clinical use of these profiles is described in two case studies. In Hemodynamic Profile 1 (Box 14-4), the example is a step-by-step interpretation of the hemodynamic profile to familiarize the reader with use of calculated values. In Hemodynamic Profile 2 (Box 14-5), the example uses only values indexed to body weight and illustrates the impact of treatment on these values over time.

Box 14-4   Hemodynamic Profile 1

Admission

Mr. SR has a medical history of cardiomyopathy and chronic obstructive pulmonary disease (COPD). He is admitted to a coronary care unit because of an exacerbation of his biventricular heart failure. He has been complaining about anginal pain and shortness of breath. His nursing diagnoses are Decreased Cardiac Output and Impaired Gas Exchange.

Height 163 cm PAD 27 mm Hg PVR 322 dyn·sec·cm−5
Weight 79 kg PAPm 36 mm Hg PVRI 612 dyn·sec·cm−5/m2
Body surface area (BSA) 1.9 m2 PAOP 26 mm Hg LCW 2.1 kg-m
    CVP 24 mm Hg LCWI 1.1 kg-m/m2
HR 104 beats/min CO 2.48 L/min LVSW 2.4 g-m
ABP   CI 1.31 L/min/m2 LVSWI 10.7 g-m/m2
 Systolic 88 mm Hg SV 23.8 mL RCW 1.21 kg-m
 Diastolic 51 mm Hg SI 12.5 mL/m2 RCWI 0.64 kg-m/m2
MAP 63 mm Hg SVR 1257 dyn·sec·cm−5 RVSW 11.7 g-m
PAS 55 mm Hg SVRI 2388 dyn·sec·cm−5/m2 RVSWI 6.2 g-m/m2

image

Analysis of the Hemodynamic Profile*

PROFILE ANALYSIS
HR (heart rate) HR of 104 beats/min is above normal limits (normal, 60-100 beats/min).
ABP (arterial blood pressure) Narrow pulse pressure of 88/51 mm Hg with a low mean arterial pressure (MAP) of 63 mm Hg (normal MAP, 65-90 mm Hg).
PAP (pulmonary artery pressure) Pulmonary artery pressures are elevated (55/27 mm Hg), consistent with diagnosis of cardiomyopathy, failure of left side of heart, and COPD (normal PAP, 25/10 mm Hg).
PAOP (pulmonary artery occlusion pressure) Elevated PAOP (26 mm Hg), consistent with diagnosis of cardiomyopathy and failure of left side of heart (normal PAOP, 5-12 mm Hg).
CVP (central venous pressure) Elevated CVP (24 mm Hg), consistent with diagnosis of cardiomyopathy, failure of right side of heart, and COPD (normal CVP, 4-6 mm Hg).
CO (cardiac output) and CI (cardiac index) Poor CO and CI (CO, 2.48 L/min; CI, 1.31 L/min/m2). Both values are below normal (normal CO, 4-6 L/min; normal CI, 2.2-4 L/min/m2).
SV (stroke volume) and SI (stroke volume index) SV and SI are low (SV, 23.8 mL; SI, 12.5 mL/m2). These results would be anticipated from the low CO (normal SV, 60-70 mL; normal SI, 40-50 mL/min/m2).
SVR (systemic vascular resistance) and SVRI (systemic vascular resistance index) SVR and SVRI are at the upper normal range (SVR, 1257 dyn·sec·cm−5; SVRI, 2388 dyn·sec·cm−5/m2). These values are not contributing to the low CO at this time (normal SVR, 800-1400 dyn·sec·cm−5; normal SVRI, 2000-2400 dyn·sec·cm−5/m2).
PVR (pulmonary vascular resistance) and PVRI (pulmonary vascular resistance index) PVR and PVRI are elevated (PVR, 322 dyn·sec·cm−5; PVRI 612 dyn·sec·cm−5/m2). High PVR may be contributing to the low CO (normal PVR, 100-250 dyn·sec·cm−5; normal PVRI, 225-315 dyn·sec·cm−5/m2).
LCWI (left cardiac work index) and LVSWI (left ventricular stroke work index) Both LCWI and LVSWI are below normal (LCWI, 1.1 kg-m/m2; LVSWI, 10.7 g-m/m2), indicating that left ventricular myocardial damage may be present. This is consistent with Mr. SR’s diagnosis of cardiomyopathy (normal LCWI, 3.4-4.2 kg-m/m2; normal LVSWI, 50-62 g-m/m2).
RCWI (right cardiac work index) and RVSWI (right ventricular stroke work index) RCWI is normal, but RVSWI is below normal (RCWI, 0.64 kg-m/m2; RVSWI, 6.2 g-m/m2), indicating that right ventricular myocardial damage may be present. This is consistent with Mr. SR’s diagnosis of cardiomyopathy and history of COPD (normal RCWI, 0.54-0.66 kg-m/m2, normal RVSWI, 7.9-9.7, g-m/m2).
Nursing impression The hemodynamic data confirm the nursing clinical diagnosis of poor CO. The goal is to improve CO within the limits of Mr. SR’s myocardial dysfunction and COPD. As CO improves and PA pressures decrease, the patient will have less pulmonary congestion, which will improve alveolar gas exchange.


*Formulas and normal values for the hemodynamics values are given in Table 14-1 and in Appendix B.

Box 14-5   Hemodynamic Profile 2

1 Admission

Mrs. JL has been admitted to the critical care unit with pulmonary edema. She has a history of anterior wall myocardial infarction and severe chronic obstructive pulmonary disease (COPD).

Height 159 cm MAP 106 mm Hg SI 9.9 mL/m2
Weight 45.8 kg PAS 53 mm Hg SVRI 5351 dyn·sec·cm−5/m2
Body surface area (BSA) 1.40 m2 PAD 27 mm Hg PVRI 1046 dyn·sec·cm−5/m2
    PAPM 44 mm Hg LCWI 1.9 kg-m/m2
HR 131 beats/min PAOP 27 mm Hg LVSWI 14.3 g-m/m2
ABP   CVP 19 mm Hg RCW 0.78 kg-m/m2
 Systolic 160 mm Hg CO 1.82 L/min RCWI 5.9 g-m/m2
 Diastolic 80 mm Hg CI 1.3 L/min/m2    

image

2 Three Hours Later

Height 159 cm MAP 83 mm Hg SI 16.5 mL/m2
Weight 45.8 kg PAS 41 mm Hg SVRI 3088 dyn·sec·cm−5/m2
Body surface area (BSA) 1.40 m2 PAD 26 mm Hg PVRI 300 dyn·sec·cm−5/m2
    PAPM 33 mm Hg LCWI 2.1 kg-m/m2
HR 113 beats/min PAOP 26 mm Hg LVSWI 18.6 g-m/m2
ABP   CVP 11 mm Hg RCWI 0.84 kg-m/m2
 Systolic 104 mm Hg CO 2.61 L/min RVSWI 7.4 g-m/m2
 Diastolic 69 mm Hg CI 1.86 L/min/m2    

image

3 The Next Day

Height 159 cm MAP 77 mm Hg SI 22.5 mL/m2
Weight 45.8 kg PAS 31 mm Hg SVRI 2423 dyn·sec·cm−5/m2
Body surface area (BSA) 1.40 m2 PAD 15 mm Hg PVRI 273 dyn·sec·cm−5/m2
    PAPM 23 mm Hg LCWI 2.4 kg-m/m2
HR 104 beats/min PAOP 15 mm Hg LVSWI 22.9 g-m/m2
ABP   CVP 4 mm Hg RCWI 0.74 kg-m/m2
 Systolic 111 mm Hg CO 3.28 L/min RVSWI 7.1 g-m/m2
 Diastolic 60 mm Hg CI 2.34 L/min/m2    

image


*See Box 14-4 for explanation of abbreviations and Table 14-1 and Appendix B for an explanation of hemodynamic values.

Noninvasive and Minimally Invasive Measurement of Cardiac Output

As a result of the perceived risks associated with use of the PA catheter, combined with studies that have not shown improved outcomes with routine monitoring, there is tremendous interest in finding less invasive methods of CO measurement. Noninvasive methods include echocardiography or bioimpedance. Minimally invasive techniques can involve vascular catheters or esophageal probes as described in Table 14-5. All have been compared with the PA catheter thermodilution CO method.

TABLE 14-5

CARDIAC OUTPUT MEASUREMENT

DEVICE NAME PROBE PLACEMENT METHOD CARDIAC OUTPUT CALCULATION CLINICAL ISSUES
Noninvasive Methods
Bioimpedance External electrodes placed on the neck and chest Thoracic electric bioimpedance

Noninvasive.
Less accurate with low body temperature.      

  Minimally Invasive Methods Pulse Contour Waveform Methods LiDCO (LiDCO Ltd., Cambridge, United Kingdom) Requires a venous access catheter (central or peripheral) and an arterial catheter with a lithium-monitoring sensor attached Pulse contour waveform analysis method (calibrated) Independent calibration with a lithium dilution technique is initially required:

Easy to set up, uses conventional venous and arterial catheters; can measure extravascular lung water for patients in pulmonary edema.       CO measurement is affected by artifact on arterial waveform and by irregular and damped arterial waveforms; can be used in conscious and in unresponsive patients.       Requires calibration at least every 8 hours to maintain accuracy; cannot be used in patients on lithium therapy because this interferes with the calibration. PiCCO (Pulsion Medical Systems, Munich, Germany) Requires a central venous access catheter and uses a specialized arterial thermistor-tipped catheter in the femoral artery Pulse contour waveform analysis method that uses transpulmonary thermodilution CO measurement is affected by artifact on arterial waveform and irregular arterial waveforms.
Three calibrations are required initially, and frequent recalibration is required to maintain accuracy. Vigileo (Edward Lifesciences, Irvine, Calif.) Requires a functional arterial catheter Pulse contour waveform analysis method (does not require calibration) Does not require external calibration but requires zeroing of the transducer.
Lack of calibration procedures is controversial.         Esophageal Probe Methods Esophageal Doppler Ultrasound probe placed in the lower esophagus SV is calculated by measurement of the aortic blood velocity in the descending thoracic aorta (by continuous wave Doppler) plus calculation of the cross-sectional area of the aorta; these values are used to calculate the CO. Useful in the operating room or with deeply sedated patients.
Probe is stiff, and placement is not well tolerated by conscious patients. Transesophageal echocardiography (TEE) Ultrasound probe placed in the esophagus Probe placement allows imaging of the LV outflow tract. SV is measured by Doppler. Useful in the operating room or with deeply sedated patients.
Probe is stiff, and placement is not well tolerated by conscious patients.
Requires skill to accurately position probe to visualize the LV outflow tract. Partial CO2 Rebreathing Method NICO2 (Philips, Respironics) Addition of a partial CO2 rebreathing circuit to ventilator Partial CO2 rebreathing method CO measurement is based on changes in respiratory CO2 concentration obtained from a short period of rebreathing. CO2 elimination is calculated by sensors that measure flow, airway pressure, and CO2 concentration. These variables are used in the Fick partial rebreathing formula to calculate CO. Can be used only in intubated and ventilated patients.
Specialized additional tubing setup on ventilator.
Cannot be used in patients who cannot tolerate hypercapnia (elevated CO2).
CO measurement is altered by intrapulmonary shunt.

image

image

CO, Cardiac output; CO2, carbon dioxide; HR, heart rate; LV, left ventricle; SV, stroke volume.

Thoracic Electrical Bioimpedance. 

Thoracic electrical bioimpedance is a noninvasive method of continuous CO measurement. Impedance cardiography works by emitting a low-voltage, high-frequency, alternating electrical current through the thorax by means of four skin electrodes. Two are placed at the base of the neck under the ear and two are placed at the side of the chest in the midaxillary line at the midxyphoid level.47 The sensing electrodes detect changes in electrical impedance within the thorax. Because blood flow through the thoracic aorta causes shifts in impedance, this information can be used to calculate SV and continuous CO. Use of thoracic electrical bioimpedance in the in-hospital setting is uncommon. One cited reason is that, although bioimpedance provides information about CO, it does not provide other clinical information such as cardiac filling pressures that may be helpful to guide treatment.48

Arterial Waveform – Pulse Contour Cardiac Output Methods.

Pulse contour waveform analysis is minimally invasive compared with the PA catheter. This method requires the patient to have a functional venous catheter and arterial catheter in place. The SV and CO are derived from the arterial waveform or pulse contour. A significant advantage of the pulse contour waveform method is that the patient does not have to be intubated or sedated to tolerate the monitoring system. Three commercial systems that use pulse contour waveform technology have undergone trials in critically ill patients.

Lithium Dilution Cardiac Output. 

The lithium dilution cardiac output system (LiDCO, LiDCO Ltd., United Kingdom) assesses the power of the arterial pressure waveform and identifies changes in arterial power to reflect changes in SV. The LiDCO Plus combines two systems: an initial calibration and ongoing assessment of the pulse waveform guided by a proprietary algorithm. To obtain an accurate baseline measure of SV and CO for calibration, a subtherapeutic dose of lithium is injected into the venous line and measured by a lithium sensor in the arterial catheter. The values obtained are comparable to thermodilution CO measurements.4951 Recalibration of the system to establish a new baseline is required about every 4 to 8 hours.52

A second system, the LiDCO rapid, a noncalibrated pulse contour system, is also available. In general, noncalibrated systems are reported to have lower levels of CO accuracy when compared with bolus thermodilution CO.53

Pulse Index Contour Cardiac Output. 

The pulse index contour cardiac output system (PiCCO2) (Pulsion Medical Systems, Germany) obtains CO by two methods, the transpulmonary CO (baseline) and a continuous CO measurement obtained by analyzing the systolic component of the arterial waveform.54,55 Three calibrations using cold saline are required at initial setup (venous injections with arterial sensor). The venous injection can be delivered from jugular or femoral venous access. The transit time is longer from the femoral artery, which causes a systematic overestimate of the CO, but once recognized, this can be accounted for by following the trend of measurements.56 The manufacturer recommends recalibration every 8 hours, although researchers reported that recalibration is required every 4 to 6 hours or even hourly to maintain accurate CO readings.5759

The PiCCO system also monitors other clinically relevant variables that offer additional information to guide management in critical illness. The extravascular lung water (EVLW) index measures the volume of lung water in lung tissue and is a marker of pulmonary edema.55 Lung water content increases in conditions such as heart failure, pneumonia, and sepsis and higher lung water content is associated with higher mortality. Knowledge of EVLW may influence whether to administer diuretics or volume.

Pulse contour analysis enables the use of stroke volume variation (SVV) to assess volume status. SVV measures the difference between the highest and lowest SV over the previous 30 seconds. The caveat is that the patient must be mechanically ventilated and not over-breathing the ventilator. This limits SVV usefulness to anesthesia, deep sedation, or pharmacologic paralysis.55

Pulse Contour Cardiac Output Method. 

The Vigileo Monitor (Edwards Lifesciences, Irvine, CA) uses pulse contour waveform technology but does not require calibration. A specialized sensor (FloTrac sensor) added to the conventional arterial line setup assesses arterial pressure at a frequency of 100 Hz to characterize the arterial pulse waveform. This information is combined with patient variables (age, sex, weight) in a proprietary algorithm to estimate SV and CO.57,60 The validation studies show conflicting results; some researchers reported that the system was not able to maintain accurate CO readings, and others found it tracked hemodynamic changes accurately in response to vasopressors.57,60

All of the pulse contour systems use different proprietary methods for the estimation of aortic impedance. For this reason, even though the mean CO values may be similar, the different methods trend CO values differently over time in response to volume and inotropic interventions.50,61

Esophageal Doppler Cardiac Output. 

The esophagus is used as the monitoring site for patients who are deeply sedated or are under general anesthesia in the operating room. The esophageal Doppler is considered less invasive than a PA catheter. Insertion of the esophageal Doppler is similar to insertion of a gastric tube, although the probe is relatively inflexible and stiff.62 The probe is inserted 35 to 40 cm from the teeth. The tip of the probe rests near T5-T6 on the vertebral column, where the esophagus typically is parallel with the descending aorta.62 There are at least three types of esophageal Doppler monitors available, with proprietary differences in the methods of CO measurement.63 When the probe is correctly placed, this method has a high degree of accuracy for CO measurement.63 Accurate CO values depend on correct placement and on the skill of the operator.64

Partial Carbon Dioxide Rebreathing Cardiac Output. 

A different technology involves partial carbon dioxide (CO2) rebreathing and uses a modified Fick principle for CO applied to CO2. This noninvasive cardiac output (NICO) system (Novametrix Medical Systems Inc., Wallingford, CT, USA), involves the addition of an extra circuit (tubing loop) to the ventilator tubing, and it can be used only with intubated, mechanically ventilated patients. A sensor that uses infrared light absorption measures CO2, and a second sensor measures airflow in the circuit tubing to collect data during a breathing cycle. CO2 production is calculated as the product of minute ventilation and CO2 concentration. Arterial CO2 content is derived from end-tidal CO2 and the CO2 dissociation curve. The differences in these values are then used to calculate the CO.65 The validation studies have produced inconsistent results for the accuracy of the derived CO; this might have resulted from intrapulmonary shunt in the critically ill. This system also requires frequent calibration.

These emerging technologies are likely to improve over time. The impetus for improvement is the push toward less invasive methods to replace the PA catheter. The different technologies have very different advantages and disadvantages, and more innovations are certainly on the horizon.

Continuous Monitoring of Venous Oxygen Saturation

Indications

Continuous monitoring of venous oxygen saturation is indicated for the critically ill patient who has the potential to develop an imbalance between oxygen supply and metabolic tissue demand. This includes patients in severe sepsis or shock, those after high-risk cardiac surgery, and patients with ARDS.66

Continuous venous oxygen monitoring permits a calculation of the balance achieved between arterial oxygen supply (Sao2) and oxygen demand at the tissue level by sampling desaturated venous blood from the PA catheter distal tip. This sample is called mixed venous oxygen saturation (Svo2) because it is a mixture of all of the venous blood drained from many body tissues. The same fiberoptic technology has been used in combination with a fiberoptic triple-lumen CVC. In this situation, the venous blood is sampled from the superior vena cava (SVC), just above the right atrium, and the Scvo2 is measured.

Under normal conditions, the cardiopulmonary system achieves a balance between oxygen supply and demand. Four factors contribute to this balance:

Three of these factors (CO, Hgb, and Sao2) contribute to the supply of oxygen to the tissues. Tissue metabolism (Vo2) determines oxygen consumption or the quantity of oxygen extracted at tissue level that creates the demand for oxygen. The relationships of these factors are illustrated in Figure 14-21.

In addition to measurement of venous oxygen saturation, it is possible to calculate the quantity of oxygen (in mL/min) that is provided to the tissues by the cardiopulmonary system and to assess the amount of oxygen consumed by the body tissues. These calculations rely on principles of oxygen transport physiology and are the basis for calculation of Svo2. These formulas are explained in greater detail in Table 14-6 and are listed in Appendix B.

TABLE 14-6

CALCULATIONS OF OXYGEN TRANSPORT PHYSIOLOGY

NAME FORMULA NORMAL VALUE EXPLANATION
Arterial oxygen saturation (Sao2)

HgbO2Hgb+HgbO2×100

image
>96% Sao2 is determined by the amount of oxygen bound to hemoglobin (Hgb), termed oxyhemoglobin (HgbO2). HgbO2 is divided by the total hemoglobin (Hgb + HgbO2). Normally, 96% of oxygen is bound to hemoglobin.
Blood oxygen content
Cao2 (arterial)
Cvo2 (venous)
(O2 dissolved) + (O2 saturation)
(Po2 × 0.003) + (1.34 × Hgb × So2)
19-20 mL/dL
12-15 mL/dL
Blood oxygen (O2) content is the amount of oxygen dissolved in 100 mL (1 dL) of blood. It can be calculated for arterial blood (Cao2) and for venous blood (Cvo2). Measured in units of mL/dL, it is the combination of dissolved O2 (Pao2) and O2 saturation (Sao2).
Blood oxygen transport (i.e., oxygen delivery) CO × Cao2 × 10 (arterial)
CO × Cvc2 × 10 (venous)
1000 mL/min
750 mL/min
Oxygen transport represents the amount (mL) of oxygen transported to or from the tissues each minute (mL/min). Arterial O2 transport is a measure of the O2 delivered to the tissues. Venous O2 transport reflects the venous return to the right side of the heart.
Oxygen transport is calculated by multiplying the cardiac output (CO) by the oxygen content (Cao2 or Cvo2) and by the number 10. The difference between normal arterial and normal venous O2 return represents oxygen consumption by the tissues.
Tissue oxygen consumption (Vo2) Arterial O2 transport minus venous O2 transport
(CO × Cao2 × 10) − (CO × CVO2 × 10)
250 mL/min Oxygen consumption is the amount of oxygen consumed by the tissues in 1 minute.
To calculate Vo2, the arterial oxygen transport and venous oxygen transport values (calculated in mL/min) must be known. The difference is Vo2.
Arterial-venous oxygen difference (a-v O2 difference) Arterial O2 content minus venous O2 content
Cao2 − CVO2
3.0-5.5 mL/dL The a-v O2 difference is the difference between the arterial oxygen content (Cao2) and the venous oxygen content (Cvo2). Because Cao2 and CVO2 are measured in mL/dL, the a-v O2 difference is also measured in mL/dL.
Mixed venous oxygen saturation (Svo2) Arterial O2 transport minus tissue O2 consumption equals venous O2 return
(CO × Cao2 × 10) − Vo2
60%-80% Svo2 is the venous oxygen return that is bound (saturated) to hemoglobin. Saturation is measured as a percentage (%). The Svo2 value is a function of the amount of oxygen delivered to the tissues minus the amount of oxygen consumed by the tissues (Vo2) and is measured in mL/min. The higher the amount (mL) of oxygen in the venous return, the greater the hemoglobin saturation.

image

Catheters

The type of catheter used to measure venous oxygen saturation is defined by where the fiberoptic tip is located, either at the tip of a CVC or on the distal tip of a PA catheter.

SCVO2 Catheter. 

The central venous Scvo2 technology is incorporated into a multilumen CVC. The fiberoptic catheter tip is positioned in a central vein, such as the SVC. The technology used to measure the venous saturation is identical in both types of catheters, and the same continuous display module is used for both catheters.

The Scvo2 catheter has been successfully used to guide hemodynamic fluid resuscitation in septic patients.27 The relationship between the values obtained from the traditional PA (Svo2) catheter and the central venous (Scvo2) catheter are very similar, although the Scvo2 values are slightly higher. The trend of parallel measurements (up or down as patient condition changes) is in the same direction most cases.

SVO2 or SCVO2 Calibration. 

The catheter is calibrated before insertion into the patient through a standardized color reference system, which is part of the catheter package. Insertion technique and sites are identical to those used for placement of conventional PA or CVC catheters. Waveform analysis or venous saturation measurement, or both, can be used for accurate placement. After the catheter is inserted, recalibration is unnecessary unless the catheter becomes disconnected from the optical module.

To recalibrate the fiberoptic module to verify accuracy when the catheter is already inserted in a patient, a mixed venous blood sample (Svo2) or central venous sample (Scvo2) must be withdrawn from the appropriate catheter tip and sent to the laboratory for oxygen saturation analysis. In many critical care units, this is a standard daily procedure to ensure that readings used to guide patient care remain accurate.67

Nursing Management

Svo2 monitoring provides a continuous assessment of the balance of oxygen supply and demand for an individual patient. Nursing assessment includes evaluation of the Svo2 or Scvo2 value and evaluation of the four factors (Sao2, CO, Hgb, and VO2) that maintain the oxygen supply–demand balance.

SVO2 or SCVO2 and Arterial Oxygen Saturation. 

A change in Svo2 or Scvo2 may be caused by a change in arterial oxygen saturation (Sao2). If the Sao2 is increased because supplemental oxygen is being administered, the Svo2 also will increase. If the oxygen supply is disrupted and Sao2 is decreased, Svo2 will decrease. The Svo2 can be decreased by any action or disease that reduces oxygen supply, including ARDS, endotracheal suctioning, removing a patient from the ventilator, or removing supplementary oxygen. Figure 14-22 demonstrates a drop in Svo2 during suctioning in a patient with ARDS. Transient decreases in Svo2 or Scvo2 related to a nursing action such as endotracheal suctioning are not usually a cause for concern. Some patients may be slow to resaturate up to the presuction level of Svo2 or Scvo2. In this case, an appropriate nursing intervention is to wait until the venous oxygen saturation has again returned to baseline before initiating other nursing activities.

SVO2 or SCVO2 and Cardiac Output. 

A change in Svo2 or Scvo2 may be caused by an alteration in CO. Four hemodynamic factors affect CO: preload, SVR, contractility, and HR (see Fig. 14-21). Changes in one or more of these individual factors affects CO. Figure 14-23 shows an improvement in a patient’s Svo2 concentration from 70% to 80% after volume administration that increased preload (point A). Later, this patient’s CO fell abruptly during a short run of ventricular tachycardia (VT) (point B). Any major loss of HR causes a decrease in CO. Alterations in contractility, preload, and afterload (SVR) also have the potential to alter CO.

Because CO is an important component of the continuous Svo2 value, researchers investigated whether Svo2 could be substituted for thermodilution CO as a monitoring tool. Studies of adult patients after cardiac surgery and acute MI indicate that a sustained change in the Svo2 value does not automatically mean there has been a change in CO. No consistent or reliable correlation was found between Svo2 and CO. Instead, a change in Svo2 indicates a need to check a CO at the bedside to determine the cause of the change in venous oxygen saturation. The Svo2 measurement is very sensitive and serves as an early warning for changes in patient condition, whether or not the change is the result of an alteration in CO. Monitoring Svo2 is an additional level of hemodynamic monitoring but does not replace thermodilution CO.

This principle is clearly illustrated in the Svo2 Hemodynamic Profile 3 (Box 14-6), in which an increase in Svo2 is not associated with a significant rise in CO. The rationale and explanation for this finding is also discussed in the section on assessment of oxygen consumption.

Box 14-6   Hemodynamic Profile 3

image

Mr. EH has just been admitted to the cardiovascular critical care unit after open heart surgery. At point A in the figure, he has an extremely low Svo2 value of 40%. An Svo2 value below 40% indicates that the oxygen supply is not adequate to meet the demands of the body tissues, resulting in metabolic acidosis. To determine the reason for the low Svo2 level, values must be known for the hemoglobin (Hgb) level, the arterial oxygen saturation (Sao2), the cardiac output (CO), and the tissue oxygen consumption (Vo2). EH’s Hgb value is 11.6 g/dL (normal male Hgb, 13.5-18.0 g/dL), which is acceptable after major surgery; the Sao2 is 99.6% (normal, 97%), which is high because this patient started receiving mechanical ventilation with 70% oxygen immediately after surgery; and the CO is low at 3.15 L/min (normal, 4-6 L/min). EH is receiving dopamine (5 mcg/kg/min) for his low CO. He is shivering and cold because his body temperature is only 35.2° C after the surgery. Using the values of Hgb of 11.6 g/dL, Sao2 of 99.6%, and CO of 3.15 L/min, it is possible to calculate the tissue oxygen consumption (Vo2) for EH.

image

To calculate arterial oxygen supply, the oxygen in the venous return, Vo2, and the difference between the arterial (a) and venous (v) oxygen content (a-v O2 difference), insert EH’s values (in boldface) into the previous formula.

image

At point A in the preceding illustration, the arterial oxygen supply to the tissues is 505 mL/min (normal, 1000 mL/min), whereas the oxygen returned in the venous blood is only 183 mL/min (normal, 750 mL/min). EH’s Vo2 is elevated at 322 mL/min (normal, 250 mL/min). The clinical goals for this patient would be to 1) increase the CO; and 2) use sedation or muscle relaxants to decrease oxygen consumption by controlling the shivering. The difference between the oxygen content in the arterial (a) and the venous (v) blood (a-v o2 difference) is very large at 10.4 mL/dL (normal, 3.5-5.0 mL/dL). These calculated values confirm the nursing diagnosis of Ineffective Tissue Perfusion with a decreased CO.

Two hours later, at point B (see illustration), EH’s Svo2 has improved to a low-normal value of 60%. Additional inotropic medications have been administered. At this time the Hgb is 10.8 g/dL, Sao2 is 99.6%, and CO remains low at 3.3 L/min. The improvement in Svo2 has not been caused by a dramatic increase in CO. When EH’s oxygen consumption is calculated at point B, it becomes evident that the decrease in physical activity after sedation with morphine to reduce shivering has improved the Svo2. EH’s values are emphasized in bold.

image

image

At point B in the illustration, EH’s arterial oxygen supply is still low at 498 mL/min, and the oxygen in his mixed venous blood return remains low at 300 mL/min. Vo2 is now lower than normal (typical after sedation) at 198 mL/min. At this time, the a-v O2 difference is almost within the normal limits at 5.7 mL/dL. These findings are confirmed by the low-normal Svo2 value of 60% at point B. This case study illustrates the point that tissue oxygen consumption (O2 demand) can be as important as cardiac output (CO) and oxygenation (O2 supply) in determining Svo2 in the patient with a compromised cardiovascular system.

See Table 14-6 for an explanation of abbreviations and Box 14-4 and Appendix B for explanation of hemodynamic values.

SVO2 or SCVO2 and Oxygen Consumption. 

Oxygen consumption Vo2 describes the amount of oxygen the body tissues consume for normal function in 1 minute. If the body’s metabolic demands increase because of exercise or increased metabolic rate, the body increases CO to augment oxygen supply and uses reserve oxygen in the venous system. Normal oxygen delivery to the tissues is 1000 mL (1 L) of oxygen per minute. At rest, a person may consume one fourth of the available oxygen, or 250 mL of oxygen per minute. This leaves a venous oxygen reserve of 750 mL of oxygen per minute (see Table 14-6). For the normal individual, the combination of increased CO and use of considerable venous oxygen reserve provides adequate compensation for increased metabolic needs. However, for the critically ill patient with cardiac or respiratory dysfunction, an increase in activity leading to increased oxygen consumption may overwhelm the cardiopulmonary system and oxygen reserves.

In the critically ill patient, nursing procedures can increase Vo2 by 10% to 36% (Table 14-7). The critical care nurse can observe the effect of increased Vo2 during routine nursing care and under conditions that increase metabolic rate. Activities such as turning, giving a backrub, or getting a patient out of bed are often accompanied by a sudden, temporary decrease in the patient’s continuous Svo2 or Scvo2 reading. After the physical activity is finished, most patients resaturate up to their preactivity venous saturation level within a few minutes. In critically ill patients, it may take up to 5 minutes for resaturation (increase in Svo2 or Scvo2) to occur. In this situation, the appropriate nursing action is to observe the patient clinically in conjunction with monitoring Svo2 or Scvo2 and to postpone additional maneuvers until the venous saturation has returned to baseline.

TABLE 14-7

ALTERATIONS IN OXYGEN CONSUMPTION

CONDITION OR ACTIVITY % INCREASE OVER RESTING Vo2 % DECREASE UNDER RESTING Vo2
Clinical Conditions That Increase Vo2
Fever 10% (for each 1° C above normal)  
Skeletal injuries 10%-30%  
Work of breathing 40%  
Severe infection 60%  
Shivering 50%-100%  
Burns 100%  
Routine postoperative procedures 7%  
Nasal intubation 25%-40%  
Endotracheal tube suctioning 27%  
Chest trauma 60%  
Multiple organ dysfunction syndrome 20%-80%  
Sepsis 50%-100%  
Head injury, with patient sedated 89%  
Head injury, with patient not sedated 138%  
Critical illness in emergency department 60%  
Nursing Activities That Increase Vo2
Dressing change 10%  
Electrocardiogram 16%  
Agitation 18%  
Physical examination 20%  
Visitor 22%  
Bath 23%  
Chest radiograph examination 25%  
Position change 31%  
Chest physiotherapy 35%  
Weighing on sling scale 36%  
Conditions That Decrease Vo2
Anesthesia   25%
Anesthesia in burned patients   50%

image

Vo2, Oxygen consumption.

Modified from White KM, et al. The physiologic basis for continuous mixed venous oxygen saturation monitoring. Heart Lung. 1990;19(5 Pt 2):548.

Many clinical conditions that dramatically increase Vo2 consumption are often seen in critical care units. Conditions such as sepsis, multiple organ dysfunction syndrome (MODS), burns, head injury, and shivering can more than double the normal oxygen tissue requirements (see Table 14-7). Such dramatic increases in Vo2 translate into a low Svo2 or Scvo2 value, even if the CO is normal. This situation is demonstrated in Hemodynamic Profile 3, in which intense shivering resulted in increased tissue oxygen consumption and a low initial Svo2 value (point A); after sedation, the Svo2 value increased due to the normalization of tissue oxygen requirements (point B).

Low SVO2 or SCVO2. 

If Svo2 or Scvo2 falls below 60% and is sustained, the clinician must assume that oxygen supply is not equal to demand (Table 14-8). It is helpful to assess the cause of decreased Svo2 or Scvo2 in a logical sequence that reflects knowledge of the meaning of the venous saturation value. The following is one such assessment sequence:

TABLE 14-8

MEASUREMENTS OF MIXED VENOUS OXYGEN SATURATION

Svo2 MEASUREMENT PHYSIOLOGIC BASIS FOR CHANGES IN Svo2/Scvo2 CLINICAL DIAGNOSIS AND RATIONALE
High Svo2 (80%-95%) Increased oxygen supply
Decreased oxygen demand
Patient receiving more oxygen than required by clinical condition
  Anesthesia, which causes sedation and decreased muscle movement
    Hypothermia, which lowers metabolic demand (e.g., during cardiopulmonary bypass)
    Sepsis caused by decreased ability of tissues to use oxygen at a cellular level
    False high-positive result because the pulmonary artery catheter is wedged in a pulmonary arteriole (Svo2 only)
Normal Svo2/Scvo2 (60%-80%) Low Svo2/Scvo2 (<60%) Normal oxygen supply and metabolic demand
Decreased oxygen supply caused by:
Balanced oxygen supply and demand
Anemia or bleeding with compromised cardiopulmonary system
Hypoxemia resulting from decreased oxygen supply or lung disease
   Low hemoglobin (Hgb) Cardiogenic shock caused by LV pump failure
   Low arterial saturation (Sao2)
 Low CO
 Increased oxygen consumption (Vo2)
Metabolic demand exceeds oxygen supply in conditions that increase muscle movement and increase metabolic rate, including physiologic states such as shivering, seizures, and hyperthermia and nursing interventions such as being weighed on a bed scale and turning

image

Scvo2, Central venous oxygen saturation; Svo2, mixed venous oxygen saturation.

The concept of target values is helpful when designing protocols for hemodynamic monitoring. Target values for venous oximetry are an Svo2 of 70% or above and a Scvo2 of 65% or above. The concept is that patients with values below these targets are at greater risk for organ hypoperfusion and increased mortality. This was seen in a study of intraoperative and postoperative surgical patients, in whom an Scvo2 below 65% was associated with increased mortality.69,70 Based on studies of patients with sepsis, the Surviving Sepsis Campaign guidelines recommend that Scvo2 be maintained above 70% for septic patients.42 This represents a clinically useful target to aim for, even as research is ongoing to find the optimal Scvo2 value to predict survival.

If Svo2 or Scvo2 falls below 40%, and is maintained at this low value, the imbalance of oxygen supply and demand will not be adequate to meet tissue needs at the cellular level. At some point, the cells change from an aerobic to anaerobic mode of metabolism, which results in the production of lactic acid and is representative of a shock state in which cellular injury or cell death may result. At this point, every attempt must be made to determine the cause of the low Svo2 or Scvo2 and to correct the oxygen supply–demand imbalance. To avoid the risk of lactic acidosis, it is helpful to watch the trend of the Svo2 or Scvo2 and to intervene early with a goal of returning the venous oxygen saturation to 70%.42